Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Boris Hadaschik

Klinik und Poliklinik für Urologie am Universitätsklinikum Essen

Anschrift
Hufelandstraße 55
45122 Essen
Telefon
+49 201 723 3211
E-Mail
boris.hadaschik@uk-essen.de

Funktionen

  • Direktor, Klinik für Urologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Hadaschik, Boris; Gillessen, Silke; Sartor, Oliver
    177Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 11, S. 1688 – 1689
    DOI
  • Di Maio, Massimo; Gonzalez-Billalabeitia, Enrique; Marandino, Laura; Maroto, Pablo; Timsit, Marc-Olivier; Luccarini, Irene; Robinson, Paul; Van Sanden, Suzy; Hadaschik, Boris
    A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer
    In: Frontiers in Oncology, Jg. 15, 2025, 1468928
    DOI (Open Access)
  • Bolenz, Christian; Grimm, Marc-Oliver; Heidenreich, Axel; Kristiansen, Glen; Schimmöller, Lars; Schmidt, Stefanie; Schostak, Martin; Hadaschik, Boris
    Aktive Überwachung des Prostatakarzinoms
    In: Best Practice Onkologie, Jg. 20, 2025, Nr. 11, S. 518 – 528
    DOI
  • Bolenz, Christian; Grimm, Marc-Oliver; Heidenreich, Axel; Kristiansen, Glen; Schimmöller, Lars; Schmidt, Stefanie; Schostak, Martin; Hadaschik, Boris
    Aktive Überwachung des Prostatakarzinoms
    In: Die Urologie, Jg. 64, 2025, Nr. 6, S. 595 – 605
    DOI
  • Vega-Rubín-de-Celis, Silvia; Kristani, Amanda; Kudla, Matthias; Mergener, Svenja; Corrochano-Ruiz, Andrés; Larafa, Safa; Montero-Vergara, Jetsy; Ahle, Laura-Marie; Will, Rainer; Lever, Mael; Grünwald, Viktor; Hadaschik, Boris; Jendrossek, Verena; Bechrakis, Nikolaos E.; Peña-Llopis, Samuel
    Autophagy suppression via SRC induction represents a therapeutic vulnerability for BAP1-mutant cancers
    In: Autophagy, 2025, in press
    DOI (Open Access)
  • Al-Monajjed, Rouvier; Schimmöller, Lars; Radtke, Jan Philipp; Lakes, Jale; Krilaviciute, Agne; Schlemmer, Heinz-Peter; Herkommer, Kathleen; Seibold, Petra; Becker, Nikolaus; Kaaks, Rudolf; Hadaschik, Boris; Antoch, Gerald; Albers, Peter; Boschheidgen, Matthias
    Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study
    In: European Urology Open Science, Jg. 75, 2025, S. 94 – 100
    DOI (Open Access)
  • Váradi, M.; Horváth, O.; Soós, E.; Csizmarik, A.; Németh, B.; Győrffy, B.; Kenessey, I.; Reis, H.; Koll, F.; Oláh, C.; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Mairinger, F.; Wessolly, M.; Hoffmann, M.J.; Grunewald, C.M.; Niegisch, G.; Cotarelo, C.L.; Maráz, A.; Kuthi, L.; Szász, A.M.; Herold, Z.; Posta, M.; Bátai, B.; Nyirády, P.; Szarvas, Tibor
    Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma
    In: Cancer Immunology, Immunotherapy, Jg. 74, 2025, Nr. 12, 370
    DOI (Open Access)
  • Wahl, Milan; Mahmuod, Osama; Krafft, Ulrich; Darr, Christopher; Radtke, Jan Philipp; Hadaschik, Boris; Panic, Andrej
    Comparison of MemoKath™ ureteral stent versus tumor ureteral stent : A single-center long-term analysis
    In: Central European Journal of Urology, Jg. 78, 2025, Nr. 2, S. 237 – 243
    DOI (Open Access)
  • Schaarschmidt, Benedikt; Zensen, Sebastian; Kesch, Claudia; Dertnig, Thomas; Opitz, Marcel; Drews, Marcel; Nadjiri, Jonathan; Forsting, Michael; Hadaschik, Boris; Haubold, Johannes
    Current use of percutaneous ablation in renal tumors : An analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy
    In: European Radiology, Jg. 35, 2025, Nr. 3, S. 1723 – 1731
    DOI (Open Access)
  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer, Jg. 6, 2025, Nr. 2, S. 307 – 322
    DOI (Open Access)
  • Carletti, Filippo; Maggi, Martina; Fazekas, Tamas; Rajwa, Pawel; Nicoletti, Rossella; Olivier, Jonathan; Preisser, Felix; Soeterik, Timo F. W.; Giganti, Francesco; Martini, Alberto; Heidegger, Isabel; Kasivisvanathan, Veeru; Pradère, Benjamin; Ploussard, Guillaume; Hadaschik, Boris; Moro, Fabrizio Dal; van den Bergh, Roderick C. N.; Marra, Giancarlo; Gandaglia, Giorgio; Zattoni, Fabio; Kesch, Claudia
    Diagnostic accuracy of multiparametric MRI for detecting unconventional prostate cancer histology : A systematic review and meta-analysis
    In: European Radiology, 2025, in press
    DOI (Open Access)
  • Olah, Csilla; Mairinger, Fabian; Wessolly, Michael; Joniau, Steven; Spahn, Martin; Kruithof-de Julio, Marianna; Hadaschik, Boris; Soós, Aron; Nyirády, Péter; Győrffy, Balázs; Reis, Henning; Szarvas, Tibor
    Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
    In: Prostate Cancer and Prostatic Diseases, Jg. 28, 2025, Nr. 3, S. 773 – 781
    DOI (Open Access)
  • Moraitis, Alexandros; Kahl, Theresa; Kandziora, Jens; Jentzen, Walter; Kersting, David; Püllen, Lukas; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Hadaschik, Boris A.; Zaidi, Habib; Herrmann, Ken; Barbato, Francesco; Fendler, Wolfgang P.; Darr, Christopher; Fragoso Costa, Pedro
    Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and their Prognostic Value in Radical Prostatectomy
    In: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 352 – 358
    DOI
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Kersting, David; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
    In: Annals of Nuclear Medicine, Jg. 39, 2025, Nr. 3, S. 255 – 265
    DOI
  • Olah, Csilla; Shmorhun, Oleksandr; Klamminger, Gilbert Georg; Rawitzer, Josefine; Sichward, Lara; Hadaschik, Boris; Al-Nader, Mulham; Krafft, Ulrich; Niedworok, Christian; Váradi, Melinda; Nyirady, Peter; Kiss, Andras; Szekely, Eszter; Reis, Henning; Szarvas, Tibor
    Immunohistochemistry-based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
    In: The Journal of Pathology: Clinical Research, Jg. 11, 2025, Nr. 1, e70017
    DOI (Open Access)
  • Al-Nader, Mulham; Krafft, Ulrich; Darr, Christopher; Heß, Jochen; Kesch, Claudia; Püllen, Lukas; Szarvas, Tibor; Reis, Henning; Tschirdewahn, Stephan; Hadaschik, Boris A.; Mahmoud, Osama
    Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical Cystectomy
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 3, 102337
    DOI
  • Karpinski, Madeleine J.; Claassen, Kevin; Möller, Lennart; Hüsing, Johannes; Kajüter, Hiltraud; Fendler, Wolfgang; Hadaschik, Boris; Stang, Andreas
    Incidence and Survival of Patients With Prostate Cancer in North-Rhine Westphalia, Germany
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 1, 102289
    DOI (Open Access)
  • Borys, Katarzyna; Haubold, Johannes; Keyl, Julius; Bali, Maria A.; De Angelis, Riccardo; Boni, Kévin Brou; Coquelet, Nicolas; Kohnke, Judith; Baldini, Giulia; Kroll, Lennard; Schramm, Sara; Stang, Andreas; Malamutmann, Eugen; Kleesiek, Jens; Kim, Moon; Kasper, Stefan; Siveke, Jens T.; Wiesweg, Marcel; Merkel-Jens, Anja; Schaarschmidt, Benedikt M.; Gruenwald, Viktor; Bauer, Sebastian; Oezcelik, Arzu; Bölükbas, Servet; Herrmann, Ken; Kimmig, Rainer; Lang, Stephan; Treckmann, Jürgen; Stuschke, Martin; Hadaschik, Boris; Umutlu, Lale; Forsting, Michael; Schadendorf, Dirk; Friedrich, Christoph M.; Schuler, Martin; Hosch, René; Nensa, Felix
    Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification
    In: npj Digital Medicine, Jg. 8, 2025, Nr. 1, 611
    DOI (Open Access)
  • Juhász, Dániel; Csizmarik, Anita; Váradi, Melinda; Bacsó, Dániel; Kubik, András; Szűcs, Miklós; Székely, Eszter; Al-Nader, Mulham; Mahmoud, Osama; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Lymphovascular Invasion is Predictive for Adjuvant Platinum Therapy Benefit in Urothelial Bladder Cancer
    In: Clinical Genitourinary Cancer, Jg. 23, 2025, Nr. 6, 102421
    DOI (Open Access)
  • Mahmoud, Osama; Püllen, Lukas; Umutlu, Lale; Szarvas, Tibor; Fendler, Wolfgang; Ting, Saskia; Reis, Henning; Bayer, Henning; Herrmann, Ken; Hadaschik, Boris; Al-Nader, Mulham; Berliner, Christoph
    Multitracer comparison of gold standard PSMA-PET/CT with 68Ga-FAPI and 18F-FDG in high-risk prostate cancer : a proof-of-concept study
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 13, S. 4860 – 4869
    DOI
  • AL-Nader, Mulham; Krafft, Ulrich; Darr, Christopher; Heß, Jochen; Kesch, Claudia; Püllen, Lukas; Tschirdewahn, Stephan; Yesilyurt, Umut-Ulas; Isgandarov, Aykhan; Hadaschik, Boris; Mahmoud, Osama
    Outcomes of surgical therapy for local recurrence and oligometastatic urothelial carcinoma of the bladder : 20 years of experience in a tertiary center
    In: Urologia Internationalis, Jg. 109, 2025, Nr. 4, S. 337 – 345
    DOI
  • Pabst, Kim M.; Siegmund, Sophie C.; Holzgreve, Adrien; Schmid, Hans P.; Bartel, Timo; Herrmann, Ken; Küper, Alina T.; Aydogdu, Can; Kersting, David; Kesch, Claudia; Hadaschik, Boris A.; Unterrainer, Marcus; Stief, Christian G.; Cyran, Clemens C.; Werner, Rudolf A.; Fendler, Wolfgang P.; Casuscelli, Jozefina; Unterrainer, Lena M.
    Potential value of [⁶⁸Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma : A bi-centric analysis
    In: European Journal of Nuclear Medicine and Molecular Imaging, 2025, in press
    DOI (Open Access)
  • Széles, Ádám; Kubik, András; Váncsa, Szilárd; Grünwald, Viktor; Hadaschik, Boris; Ács, Nándor; Hegyi, Péter; Nyirády, Péter; Szarvas, Tibor
    Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors : A systematic review and meta-analysis
    In: Frontiers in Immunology, Jg. 16, 2025, 1554048
    DOI, Online Volltext (Open Access)
  • Telli, Tugce; Lopes, Leonor; Karpinski, Madeleine; Pabst, Kim M.; Grünwald, Viktor; Shi, Kuangyu; Hadaschik, Boris; Kesch, Claudia; Umutlu, Lale; Herrmann, Ken; Seifert, Robert; Fendler, Wolfgang
    Prognostic value of [¹⁸F]FDG- and PSMA-PET in patients evaluated for [¹⁷⁷Lu]Lu-PSMA therapy of mCRPC
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2025, Nr. 9, S. 3199 – 3210
    DOI (Open Access)
  • Al-Monajjed, Rouvier; Boschheidgen, Matthias; Lakes, Jale; Krilaviciute, Agne; Radtke, Jan-Philipp; Schlemmer, Heinz-Peter; Bonekamp, David; Herkommer, Kathleen; Jahnen, Matthias; Gschwend, Jürgen E.; Düx, Daniel; Wacker, Frank; Makowski, Marcus R.; Sauter, Andreas; Kuczyk, Markus A.; Harke, Nina; Debus, Jürgen; Grott, Christoph; Arsov, Christian; Seibold, Petra; Hadaschik, Boris; Giesel, Frederik; Kristiansen, Glenn; Antoch, Gerald; Becker, Nikolaus; Kaaks, Rudolf; Schimmöller, Lars; Albers, Peter
    Prostate Cancer Detection in Younger Men : A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial
    In: European Urology, Jg. 88, 2025, Nr. 3, S. 240 – 244
    DOI (Open Access)
  • Karpinski, Madeleine J.; Kesch, Claudia; Hadaschik, Boris; Fendler, Wolfgang
    Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrence
    In: Current Opinion in Urology, Jg. 35, 2025, Nr. 5, S. 506 – 509
    DOI
  • Thomas, Christian; Hadaschik, Boris
    Re: Salvage Metastasis-directed Therapy Versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V–STORM) : A Phase 2, Open-label, Randomised Controlled Trial
    In: European Urology, Jg. 88, 2025, Nr. 6, S. 633 – 634
    DOI
  • Horváth, András; Blasszauer, Celia; Komka, Ida; Reibl, Dániel; Hadaschik, Boris; Fazekas, Tamás; Rajwa, Pawel; Soós, Àron; Valikovics, Anikó; Nyirády, Péter; Szarvas, Tibor
    Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer
    In: The Prostate, Jg. 85, 2025, Nr. 12, S. 1151 – 1154
    DOI (Open Access)
  • Karpinski, Madeleine J.; Hadaschik, Boris A.; Fendler, Wolfgang P.
    Reply to Zhengbo Pan, Run Shi, and Zhaokai Zhou's Letter to the Editor - Re: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, et al. Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study. Eur Urol. 2025;88:484–495
    In: European Urology, Jg. 88, 2025, Nr. 5, S. e100 – e101
    DOI
  • Herrmann, Ken; Walz, Jochen; MacLennan, Steven; Briganti, Alberto; Cornford, Philip; Czernin, Johannes; Eiber, Matthias; Fanti, Stefano; Fendler, Wolfgang P.; Fizazi, Karim; Gafita, Andrei; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Hofman, Michael S.; Hope, Thomas A.; Maurer, Tobias; Morgans, Alicia K.; Morris, Michael J.; Murphy, Declan G.; Oprea-Lager, Daniela E.; Ost, Piet; ÓSullivan, Joe M.; Rouvière, Olivier; Sandhu, Shahneen; Sartor, Oliver; Sathekge, Mike Machaba; Tempany, Clare; Witjes, Wim; Emmett, Louise; Bjartell, Anders S.
    SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus ; A Delphi Analysis
    In: European Urology, 2025, in press
    DOI (Open Access)
  • Al-Monajjed, Rouvier; Albers, Peter; Hadaschik, Boris
    Screening for Prostate Cancer with Prostate-specific Antigen
    In: European Urology Open Science, Jg. 74, 2025, S. 71 – 72
    DOI (Open Access)
  • Olah, Csilla; Sichward, Lara; Hadaschik, Boris; Darr, Christopher; Grünwald, Viktor; Krafft, Ulrich; Grünwald, Barbara; Mahmoud, Osama; Al-Nader, Mulham; Nyirady, Peter; Reis, Henning; Szarvas, Tibor
    Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer
    In: BJU International (BJUI), Jg. 136, 2025, Nr. 2, S. 297 – 305
    DOI (Open Access)
  • Kesch, Claudia; Franiel, Tobias; Berliner, Christoph; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris
    Stellenwert der PSMA-PET/CT („prostate-specific membrane antigen positron emission tomography/computed tomography“) im Rahmen des Stagings
    In: Die Urologie, Jg. 64, 2025, Nr. 3, S. 220 – 228
    DOI
  • Al-Nader, Mulham; Krafft, Ulrich; Heß, Jochen A.; Püllen, Lukas; Szarvas, Tibor; Tschirdewahn, Stephan; Hadaschik, Boris; Mahmoud, Osama
    Temporal patterns of major postoperative events after radical cystectomy : Analysis of 90-day morbidity
    In: World Journal of Urology, Jg. 43, 2025, Nr. 1, 111
    DOI
  • Karpinski, Madeleine J.; Rahbar, Kambiz; Bögemann, Martin; Nikoukar, Laya Rahbar; Schäfers, Michael; Hoberück, Sebastian; Miederer, Matthias; Hölscher, Tobias; Rasul, Sazan; Miszczyk, Marcin; Lanfranchi, Francesco; Bauckneht, Matteo; Pfob, Christian H.; Kind, Felix; Goffin, Karolien; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Stuschke, Martin; Gafita, Andrei; Hüsing, Johannes; Calais, Jeremie; Hofman, Michael S.; Hope, Thomas A.; Miksch, Jonathan; Soeterik, Timo F.W.; Di Giorgio, Andrea; Farolfi, Andrea; Bjartell, Anders; Trägårdh, Elin; Unterrainer, Lena M.; Holzgreve, Adrien; Sheikh, Gabriel T.; Rauscher, Isabel; Eiber, Matthias; Hadaschik, Boris A.; Fendler, Wolfgang P.; Rodriguez SantAnna Jauregui, Nadir; Hacker, Marcus; Shariat, Shahrokh F.; Fornarini, Giuseppe; Terrone, Carlo; Ahmadi Bidakhvidi, Niloefar; Evangelista, Laura; Santangelo, Alfonso; Vondrak, Andrej; van Melick, Harm H.E.; Rapa, Marco; Bianchi, Lorenzo; Rastbäck, Anniqa; Andersson, Åsa; Kunte, Sophie C.; Späth, Lukas; Hempel, Linus; Coban, Ömür
    Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study
    In: European Urology, Jg. 88, 2025, Nr. 5, S. 484 – 495
    DOI (Open Access)
  • Meissner, Valentin H.; Dinkel, Andreas; Kron, Martina; Schiele, Stefan; Jahnen, Matthias; Lakes, Jale; Radtke, Jan Philipp; Kuczyk, Markus A.; Harke, Nina N.; Debus, Jürgen; Fink, Christoph A.; Antoch, Gerald; Schimmöller, Lars; Kristiansen, Glen; Krilaviciute, Agne; Seibold, Petra; Behrens, Sabine; Benner, Axel; Arsov, Christian; Hadaschik, Boris; Becker, Nikolaus; Kaaks, Rudolf; Albers, Peter; Gschwend, Jürgen E.; Herkommer, Kathleen
    Worry about prostate cancer and risk perception among middle-aged men : results from the PROBASE trial
    In: Journal of Behavioral Medicine, Jg. 48, 2025, Nr. 3, S. 464 – 477
    DOI (Open Access)
  • Pabst, Kim M; Weber, Manuel; Laschinsky, Christina; Sandach, Patrick; Bartel, Timo; Küper, Alina T; Kessler, Lukas; Trajkovic-Arsic, Marija; Eckstein, Markus; Gilman, Elena; Nader, Michael; Barbato, Francesco; Podleska, Lars; Hadaschik, Boris; Hamacher, Rainer; Kersting, David; von Ostau (N.), Nicola; von Tresckow, Bastian; Kaelberlah, Hans-Peter; Kesch, Claudia; Kuemmel, Sherko; Reinacher-Schick, Anke; Schuler, Martin; Siveke, Jens; Grünwald, Viktor; Herrmann, Ken; Fendler, Wolfgang P.
    [⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trial
    In: The Lancet Oncology, Jg. 26, 2025, Nr. 9, S. 1204 – 1214
    DOI (Open Access)
  • Chi, Kim Nguyen; McKay, Rana R; Sandhu, Shahneen; Arranz, Jose A; Barthélémy, Philippe; Hadaschik, Boris; Matsubara, Nobuaki; Shore, Neal D; Ye, Dingwei; Cascella, Teresa; Irincheeva, Irina; Kreiser, Stephanie; Thiery-Vuillemin, Antoine; Rathkopf, Dana E
    rechARge : A randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator’s choice in patients with mCRPC
    In: Future Oncology, Jg. 21, 2025, Nr. 14, S. 1771 – 1777
    DOI (Open Access)
  • Flippot, Ronan; Telli, Tugce; Velev, Maud; Fléchon, Aude; De Vries-Brilland, Manon; Turpin, Léa; Bergman, Andries; Turco, Fabio; Mahammedi, Hakim; Fendler, Wolfgang; Giraudet, Anne-Laure; Josset, Quentin; Montravers, Françoise; Vogel, Wouter; Gillessen, Silke; Berardi Vilei, Simona; Herrmann, Ken; Kryza, David; Paone, Gaetano; Hadaschik, Boris; Merlin, Charles; Dufour, Pierre-Alban; Bernard-Tessier, Alice; Naoun, Natacha; Patrikidou, Anna; Garcia, Camilo; Foulon, Stéphanie; Pagès, Arnaud; Fizazi, Karim
    Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study
    In: European Urology Oncology, Jg. 7, 2024, Nr. 5, S. 1132 – 1140
    DOI
  • von Ostau, Nicola Edith; Handke, Analena Elisa; Wiesenfarth, Manuel; Albers, Peter; Antoch, Gerald; Noldus, Joachim; Reis, Henning; Cotarelo, Cristina; Preetz, Julia; Umutlu, Lale; Ingenwerth, Marc; Radtke, Jan Philipp; Hadaschik, Boris; Schimmöller, Lars; Kesch, Claudia
    Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters
    In: World Journal of Urology, Jg. 42, 2024, Nr. 1, 530
    DOI (Open Access)
  • Al-Nader, Mulham; Krafft, Ulrich; Heß, Jochen A.; Kesch, Claudia; AbdelRazek, Mostafa; Abolyosr, Ahmad; Alsagheer, Gamal A.; Mohamed, Omar; Fathi, Atef; Tschirdewahn, Stephan; Hadaschik, Boris; Mahmoud, Osama
    Bricker versus Wallace ureteroileal anastomosis : A multi-institutional propensity score-matched analysis
    In: International Journal of Urology, Jg. 31, 2024, Nr. 7, S. 813 – 818
    DOI (Open Access)
  • Karpinski, Madeleine J; Hüsing, Johannes; Claassen, Kevin; Möller, Lennart; Kajüter, Hiltraud; Oesterling, Florian; Grünwald, Viktor; Umutlu, Lale; Kleesiek, Jens; Telli, Tugce; Merkel-Jens, Anja; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Eiber, Matthias; Hoberück, Sebastian; Meyer, Philipp T; Kind, Felix; Rahbar, Kambiz; Schäfers, Michael; Stang, Andreas; Hadaschik, Boris A.; Fendler, Wolfgang P.
    Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer : A multicentre retrospective study
    In: The Lancet Oncology, Jg. 25, 2024, Nr. 9, S. 1188 – 1201
    DOI (Open Access)
  • Katzendorn, Olga; Schiefelbein, Frank; Schoen, Georg; Wiesinger, Clemens; Pfuner, Jacob; Ubrig, Burkhard; Gloger, Simon; Osmonov, Daniar; Eraky, Ahmed; Wagner, Christian; Ayanle, Abdirahman; Al-Nadar, Mulham; Kesch, Claudia; Hadaschik, Boris A.; Faraj Tabrizi, Pouriya; Wolters, Mathias; Kuczyk, Markus A.; Siemer, Stefan; Stoeckle, Michael; Zeuschner, Philip; Harke, Nina N.
    Conversions in robot-assisted partial nephrectomy : a multicentric analysis of 2549 cases
    In: Minerva Urology and Nephrology, Jg. 76, 2024, Nr. 6, S. 708 – 716
    DOI
  • Pabst, Kim M.; Mei, Riccardo; Lückerath, Katharina; Hadaschik, Boris; Kesch, Claudia; Rawitzer, Josefine; Kessler, Lukas; Bodensieck, Luisa S.; Hamacher, Rainer; Pomykala, Kelsey L.; Fanti, Stefano; Herrmann, Ken; Fendler, Wolfgang
    Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [⁶⁸Ga]Ga-/[¹⁸F]F-PSMA-11/-1007, [⁶⁸Ga]Ga-FAPI-46 and 2-[¹⁸F]FDG PET/CT : a pilot study
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 52, 2024, Nr. 1, S. 342 – 353
    DOI (Open Access)
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 372 – 378
    DOI (Open Access)
  • Farolfi, Andrea; Armstrong, Wesley R.; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Allen-Auerbach, Martin; Unterrainer, Lena M.; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael S.; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias R.
    Differences and Common Ground in ¹⁷⁷Lu-PSMA Radioligand Therapy Practice Patterns : International Survey of 95 Theranostic Centers
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 438 – 445
    DOI (Open Access)
  • Brehmer, Alexander; Sauer, Christopher Martin; Salazar Rodríguez, Jayson; Herrmann, Kelsey; Kim, Moon; Keyl, Julius; Bahnsen, Fin Hendrik; Frank, Benedikt; Köhrmann, Martin; Rassaf, Tienush; Mahabadi, Amir Abbas; Hadaschik, Boris; Darr, Christopher; Herrmann, Ken; Tan, Susanne; Buer, Jan; Brenner, Thorsten; Reinhardt, Hans Christian; Nensa, Felix; Gertz, Michael; Egger, Jan; Kleesiek, Jens
    Establishing Medical Intelligence - Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management : Retrospective Cohort and Clinical Implementation Study
    In: Journal of Medical Internet Research (JMIR), Jg. 26, 2024, e55148
    DOI, Online Volltext (Open Access)
  • Barakat, Bara; Hadaschik, Boris; Al-Nader, Mulham; Schakaki, Samer
    Factors Contributing to Early Recovery of Urinary Continence Following Radical Prostatectomy : A Narrative Review
    In: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 22, 6780
    DOI (Open Access)
  • Kowalski, Christoph; Sibert, Nora Tabea; Hammerer, Peter; Wesselmann, Simone; Feick, Günter; Carl, Ernst-Günther; Klotz, Theodor; Apel, Hendrik; Dieng, Sebastian; Nyarangi-Dix, Joanne; Knoll, Thomas; Reike, Moritz Johannes; Duwe, Gregor; Bartolf, Elisabeth; Steiner, Thomas; Borowitz, Rainer; Lümmen, Gerd; Seitz, Anna Katharina; Pfitzenmaier, Jesco; Aziz, Atiqullah; Brock, Marko; Berger, Frank Peter; Kaftan, Björn Theodor; Grube, Christian; Häfner, Tim; Hamza, Amir; Schmelz, Hans; Haas, Jürgen; Lenart, Sebastian; Lafita, Anselm; Sippel, Carsten; Winter, Alexander; Kedia, George; Hadaschik, Boris; Varga, Zoltan; Buse, Stephan; Richter, Matthias; Distler, Florian; Simon, Jörg; Wiegel, Thomas; Baltes, Stefan; Janitzky, Andreas; Sommer, Jens Peter; Hijazi, Sameh; Fülkell, Philipp; Harke, Nina N.; Bolenz, Christian; Khalil, Christian; Breidenbach, Clara; Tennstedt, Pierre; Burchardt, Martin
    Harninkontinenz nach radikaler Prostatektomie beim Prostatakarzinom  : Aktuelle Daten von 17.149 Patienten aus 125 zertifizierten Zentren
    In: Die Urologie, Jg. 63, 2024, Nr. 1, S. 67 – 74
    DOI
  • Gartrell, Benjamin A.; Phalguni, Angaja; Bajko, Paulina; Mundle, Suneel D.; McCarthy, Sharon A.; Brookman-May, Sabine D.; De Solda, Francesco; Jain, Ruhee; Yu Ko, Wellam; Ploussard, Guillaume; Hadaschik, Boris
    Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer : A Systematic Literature Review
    In: European Urology Oncology, Jg. 7, 2024, Nr. 6, S. 1216 – 1227
    DOI (Open Access)
  • Grünwald, Viktor; Hadaschik, Boris; Klümper, Niklas; Herrmann, Ken
    Kick-Starting Molecular Theranostics in Renal Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 5, S. 744 – 745
    DOI (Open Access)
  • Valentin, Birte; Arsov, Christian; Ullrich, Tim; Al-Monajjed, Rouvier; Boschheidgen, Matthias; Hadaschik, Boris A.; Giganti, Francesco; Giessing, Markus; Lopez-Cotarelo, Cristina; Esposito, Irene; Antoch, Gerald; Albers, Peter; Radtke, Jan Philipp; Schimmöller, Lars
    Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer : The Prospective PROMM-AS Study
    In: European Urology Open Science, Jg. 59, 2024, S. 30 – 38
    DOI (Open Access)
  • Claaßen, Kevin; Karpinski, Madeleine; Kajüter, Hiltraud; Hüsing, Johannes; Möller, Lennart; Wellmann, Ina; Grünwald, Viktor; Hadaschik, Boris; Albers, Peter; Stang, Andreas
    Mortality from prostate cancer in the years 2007–2021 in North Rhine-Westphalia, Germany
    In: BMC Urology, Jg. 24, 2024, Nr. 1, 181
    DOI (Open Access)
  • Locherer, Mark; Bonenberger, Christopher; Ertel, Wolfgang; Hadaschik, Boris; Stumm, Kristina; Schneider, Markus; Radtke, Jan Philipp
    Multi-label semantic segmentation of magnetic resonance images of the prostate gland
    In: Discover Artificial Intelligence, Jg. 4, 2024, Nr. 1, 66
    DOI (Open Access)
  • Boschheidgen, Matthias; Albers, Peter; Schlemmer, Heinz-Peter; Hellms, Susanne; Bonekamp, David; Sauter, Andreas; Hadaschik, Boris; Krilaviciute, Agne; Radtke, Jan Philipp; Seibold, Petra; Lakes, Jale; Arsov, Christian; Gschwend, Jürgen E.; Herkommer, Kathleen; Makowski, Marcus; Kuczyk, Markus A.; Wacker, Frank; Harke, Nina; Debus, Jürgen; Körber, Stefan A.; Benner, Axel; Kristiansen, Glen; Giesel, Frederik L.; Antoch, Gerald; Kaaks, Rudolf; Becker, Nikolaus; Schimmöller, Lars
    Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years : Results from the First Screening Round of the PROBASE Trial
    In: European Urology, Jg. 85, 2024, Nr. 2, S. 105 – 111
    DOI
  • Püllen, Lukas; Costa, Pedro F.; Darr, Christopher; Heß, Jochen A.; Kesch, Claudia; Rehme, Christian R.; Wahl, Milan; Yirga, Leubet; Reis, Henning; Szarvas, Tibor; van Leeuwen, Fijs W. B.; Herrmann, Ken; Hadaschik, Boris; Tschirdewahn, Stephan; Krafft, Ulrich
    Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experience
    In: Journal of Surgical Oncology, Jg. 129, 2024, Nr. 7, S. 1325 – 1331
    DOI (Open Access)
  • Al-Monajjed, Rouvier; Albers, Peter; Droop, Johanna; Fugmann, Dominik; Noldus, Joachim; Palisaar, Rein-Jüri; Ritter, Manuel; Ellinger, Jörg; Krausewitz, Philipp; Truß, Michael; Hadaschik, Boris; Grünwald, Viktor; Schrader, Andres-Jan; Papavassilis, Philipp; Ernstmann, Nicole; Schellenberger, Barbara; Moritz, Anna; Kowalski, Christoph; Hellmich, Martin; Heiden, Pierce; Hagemeier, Anna; Horenkamp-Sonntag, Dirk; Giessing, Markus; Pauler, Luis; Dieng, Sebastian; Peters, Maria; Feick, Günter; Karger, André; PRO-P Study Group
    PRO-P : Evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
    In: Trials, Jg. 25, 2024, Nr. 1, 754
    DOI (Open Access)
  • Santiago Almeida, Ludmila; Etchebehere, Elba Cristina Sá de Camargo; García Megías, Irene; Calapaquí Terán, Adriana K.; Hadaschik, Boris; Colletti, Patrick M.; Herrmann, Ken; Giammarile, Francesco; Delgado Bolton, Roberto C.
    PSMA Radioligand Therapy in Prostate Cancer Where Are We and Where Are We Heading?
    In: Clinical Nuclear Medicine, Jg. 49, 2024, Nr. 1, S. 45 – 55
    DOI
  • Küper, Alina T.; Kersting, David; Telli, Tugce; Herrmann, Ken; Rominger, Axel; Afshar-Oromieh, Ali; Lopes, Leonor; Karkampouna, Sofia; Shi, Kuangyu; Kim, Moon; Hadaschik, Boris; Darr, Christopher; Umutlu, Lale; Fendler, Wolfgang; Seifert, Robert
    PSMA-PET follow-up to assess response in patients not receiving PSMA therapy : Is there value beyond localization of disease?
    In: Theranostics, Jg. 14, 2024, Nr. 9, S. 3623 – 3633
    DOI, Online Volltext (Open Access)
  • Hadaschik, Boris; Karpinski, Madeleine J; Hüsing, Johannes; Fendler, Wolfgang P.
    PSMA-PET research: addressing challenges and prospects : Authors' reply
    In: The Lancet Oncology, Jg. 25, 2024, Nr. 11, e533
    DOI
  • Fazekas, Tamás; Széles, Ádám D; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Kói, Tamás; Ács, Nándor; Hegyi, Péter; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer : A Systematic Review and Meta-analysis
    In: European Urology Oncology, Jg. 7, 2024, Nr. 3, S. 365 – 375
    DOI (Open Access)
  • Barakat, Bara; Addali, Mustapha; Hadaschik, Boris; Rehme, Christian R.; Hijazi, Sameh; Zaqout, Samy
    Predictors of Early Continence Recovery Following Radical Prostatectomy, Including Transperineal Ultrasound to Evaluate the Membranous Urethra Length (CHECK-MUL Study)
    In: Diagnostics, Jg. 14, 2024, Nr. 8, 853
    DOI (Open Access)
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 7, S. 1027 – 1034
    DOI
  • Weber, Manuel; Fendler, Wolfgang P.; Ravi Kumar, Aravind S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Kretschmer, Alexander; Hekimsoy, Turkay; Brookman-May, Sabine D.; Mundle, Suneel D.; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Herrmann, Ken; Hofman, Michael S.; Eiber, Matthias; Hadaschik, Boris A.
    Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer : An International Multicenter Retrospective Study
    In: European Urology, Jg. 85, 2024, Nr. 6, S. 511 – 516
    DOI (Open Access)
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Solnes, Lilja B.; Calais, Jeremie; Rettig, Matthew B.; Weber, Manuel; Farolfi, Andrea; Benz, Matthias R.; Eiber, Matthias
    RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 917 – 922
    DOI
  • Nikitas, John; Lam, Ethan; Booker, Kiara Adame; Fendler, Wolfgang; Eiber, Matthias; Hadaschik, Boris; Herrmann, Ken; Hirmas, Nader; Lanzafame, Helena; Stuschke, Martin; Czernin, Johannes; Steinberg, Michael L.; Nickols, Nicholas G.; Kishan, Amar U.; Calais, Jeremie
    Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 7, S. 1076 – 1079
    DOI
  • Klümper, Niklas; Vera-Badillo, Francisco E.; Eckstein, Markus; Hadaschik, Boris; Grünwald, Viktor
    Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
    In: European Urology, Jg. 86, 2024, Nr. 3, S. 280 – 281
    DOI
  • Jannusch, Kai; Bruckmann, Nils Martin; Morawitz, Janna; Boschheidgen, Matthias; Quick, Harald H.; Herrmann, Ken; Fendler, Wolfgang; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Antoch, Gerald; Schimmöller, Lars; Kirchner, Julian
    Recurrent prostate cancer : combined role for MRI and PSMA-PET in ⁶⁸Ga-PSMA-11 PET/MRI
    In: European Radiology, Jg. 34, 2024, Nr. 7, S. 4789 – 4800
    DOI (Open Access)
  • Mahmoud, Osama; Krafft, Ulrich; Al-Nader, Mulham; Heβ, Jochen; Kesch, Claudia; AbdelRazek, Mostafa; Abolyosr, Ahmad; Alsagheer, Gamal A; Mohamed, Omar; Fathi, Atef; Hadaschik, Boris; Tschirdewahn, Stephan; Heß, Jochen A.
    Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion : A systematic review
    In: Arab Journal of Urology, Jg. 22, 2024, Nr. 1, S. 61 – 69
    DOI (Open Access)
  • Krilaviciute, Agne; Kaaks, Rudolf; Seibold, Petra; de Vrieze, Maxime; Lakes, Jale; Radtke, Jan Philipp; Kuczyk, Markus; Harke, Nina N.; Debus, Jürgen; Fink, Christoph A.; Herkommer, Kathleen; Gschwend, Jürgen E.; Meissner, Valentin H.; Benner, Axel; Kristiansen, Glen; Hadaschik, Boris; Arsov, Christian; Schimmöller, Lars; Antoch, Gerald; Giesel, Frederik L.; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz-Peter; Becker, Nikolaus; Albers, Peter
    Risk-adjusted Screening for Prostate Cancer—Defining the Low-risk Group by Data from the PROBASE Trial
    In: European Urology, Jg. 86, 2024, Nr. 6, S. 493 – 500
    DOI (Open Access)
  • Faraj Tabrizi, Pouriya; Zeuschner, Philip; Katzendorn, Olga; Schiefelbein, Frank; Schneller, Andreas; Schoen, Georg; Ubrig, Burkhard; Gloger, Simon; Wiesinger, Clemens G.; Pfuner, Jacob; Falkensammer, Eva; Eraky, Ahmed; Osmonov, Daniar; Nuhn, Philipp; Zimmermanns, Volker; Paramythelli, Ionna; Hadaschik, Boris A.; Radtke, Jan P.; Darr, Christopher; Gilbert, Nils; Kriegmair, Maximilian; Fuhrmann, Christian; Kuczyk, Markus A.; Harke, Nina N.
    Robot-assisted partial nephrectomy of multiple tumors : A multicenter analysis
    In: Minerva Urology and Nephrology, Jg. 76, 2024, Nr. 6, S. 698 – 707
    DOI
  • Seifert, Robert; Telli, Tugce; Lapa, Constantin; Desaulniers, Mélanie; Hekimsoy, Turkay; Weber, Wolfgang A.; Pfob, Christian; Hadaschik, Boris; Bögemann, Martin; Schäfers, Michael; Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Fendler, Wolfgang
    Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA : A German Multicenter Study
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 909 – 916
    DOI
  • Afferi, Luca; Spahn, Martin; Hayoz, Stefanie; Strebel, Räto T.; Rothschild, Sacha I.; Seifert, Helge; Özdemir, Berna C.; Kiss, Bernhard; Maletzki, Philipp; Engeler, Daniel; Wirth, Gregory; Hadaschik, Boris; Lucca, Ilaria; John, Hubert; Sauer, Andreas; Müntener, Michael; Bubendorf, Lukas; Schneider, Martina; Musilova, Jana; Petrausch, Ulf; Cathomas, Richard
    Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine
    In: BJU International (BJUI), Jg. 134, 2024, Nr. 3, S. 388 – 397
    DOI
  • Püllen, Lukas; Naumann, Max; Krafft, Ulrich; Püllen, Felix; Mahmoud, Osama; Al-Nader, Mulham; Darr, Christopher; Borgmann, Hendrik; Briel, Christoph; Hadaschik, Boris; Salem, Johannes; Kuru, Timur
    Short-Term Urinary Incontinence After Radical Prostatectomy Is Still Based on Patients' Age, Nerve-Sparing Approach, and Surgical-Experience, Despite the Higher-Use of Robotic Surgery in 2022 Compared to 2016 Real-World Results of a Large Rehabilitation Center in Germany
    In: Cancer Reports, Jg. 7, 2024, Nr. 12, e70092
    DOI (Open Access)
  • Pettinella, Francesca; Mariotti, Barbara; Lattanzi, Chiara; Bruderek, Kirsten; Donini, Marta; Costa, Sara; Marini, Olivia; Iannoto, Giulia; Gasperini, Sara; Caveggion, Elena; Castellucci, Monica; Calzetti, Federica; Bianchetto-Aguilera, Francisco; Gardiman, Elisa; Giani, Matteo; Dusi, Stefano; Cantini, Maurizio; Vassanelli, Aurora; Pavone, Denise; Milella, Michele; Pilotto, Sara; Biondani, Pamela; Höing, Benedikt; Schleupner, Marie Carolin; Hussain, Timon; Hadaschik, Boris; Kaspar, Cordelia; Visco, Carlo; Tecchio, Cristina; Koenderman, Leo; Bazzoni, Flavia; Tamassia, Nicola; Brandau, Sven; Cassatella, Marco A.; Scapini, Patrizia
    Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
    In: Cell Reports Medicine, Jg. 5, 2024, Nr. 2, 101380
    DOI (Open Access)
  • Maurer, Tobias; Thomas, Christian; Hadaschik, Boris
    The DETECT Trial : Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 430 – 431
    DOI (Open Access)
  • Mahmoud, Osama; Al-Nader, Mulham; Püllen, Lukas; Tschirdewahn, Stephan; Hadaschik, Boris
    The current role of pentafecta in the reporting of radical cystectomy outcomes : a scoping review
    In: Translational Andrology and Urology, Jg. 13, 2024, Nr. 6, S. 1037 – 1048
    DOI (Open Access)
  • Handke, Analena; Bargen, Marla Geller-von; Isgandarov, Aykhan; al Nader, Mulham; Krafft, Ulrich; Darr, Christopher; Hadaschik, Boris; Grünwald, Viktor; Püllen, Lukas
    The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
    In: Scientific Reports, Jg. 14, 2024, Nr. 1, 28141
    DOI (Open Access)
  • Mahmoud, Osama; Krafft, Ulrich; Heb, Jochen; Kesch, Claudia; Tschirdewahn, Stephan; Hadaschik, Boris; Püllen, Lukas; Al-Nader, Mulham; Heß, Jochen A.
    The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinoma
    In: Minerva Urology and Nephrology, Jg. 76, 2024, Nr. 4, S. 442 – 451
    DOI
  • von Ostau, Nicola E.; Martynov, Aleksandr; Schreiber, Janina; Wiesehöfer, Marc; Hadaschik, Boris A.; Temme, Christian; Stang, Andreas; Dankert, Jaroslaw T.; Wiesehöfer, Caroline; Wennemuth, Gunther
    Transient Decrease in Sperm Motility after Plateletpheresis
    In: Exposure and Health, Jg. 16, 2024, Nr. 5, S. 1263 – 1277
    DOI (Open Access)
  • Radtke, Jan Philipp; Albers, Peter; Hadaschik, Boris; Graefen, Markus; Meyer, Christian P.; Behr, Björn; Nüesch, Stephan
    Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card
    In: Healthcare, Jg. 12, 2024, Nr. 10, 991
    DOI (Open Access)
  • Costa, Pedro Fragoso; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Tschirdewahn, Stephan; Moraitis, Alexandros; Radtke, Jan Philipp; Ting, Saskia; Nader, Michael; Wosniack, Jasmin; Kersting, David; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Hadaschik, Boris; Darr, Christopher
    18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 4, S. 598 – 604
    DOI (Open Access)
  • Abascal Junquera, Jose M.; Harke, Nina N.; Walz, Jochen C.; Hadaschik, Boris; Adshead, Jim; Everaerts, Wouter; Goffin, Karolien; Grootendorst, Maarten R.; Oldfield, Francesca; Vyas, Kunal; Fusco, Antoni Mestre; Juanpere, Nuria; Vidal-Sicart, Sergi; Fumado, Lluis
    A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer : Preclinical Evaluation and Interim Results From a Multicenter Clinical Trial
    In: Clinical Nuclear Medicine, Jg. 48, 2023, Nr. 3, S. 213 – 220
    DOI
  • Krilaviciute, Agne; Albers, Peter; Lakes, Jale; Radtke, Jan Philipp; Herkommer, Kathleen; Gschwend, Jürgen; Peters, Inga; Kuczyk, Markus; Koerber, Stefan A.; Debus, Jürgen; Kristiansen, Glen; Schimmöller, Lars; Antoch, Gerald; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz; Benner, Axel; Giesel, Frederik; Siener, Roswitha; Arsov, Christian; Hadaschik, Boris; Becker, Nikolaus; Kaaks, Rudolf
    Adherence to a risk-adapted screening strategy for prostate cancer : First results of the PROBASE trial
    In: International Journal of Cancer, Jg. 152, 2023, Nr. 5, S. 854 – 864
    DOI (Open Access)
  • Handke, Analena; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Yang; Hakansson, Alexander; Davicioni, Elai; Hughes, Jason; Song, Hong; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
    In: Journal for ImmunoTherapy of Cancer, Jg. 11, 2023, Nr. 10, e007354
    DOI (Open Access)
  • Pollock, YaoYao; Smith, Matthew R; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Olmos, David; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Brendan; Brookman-May, Sabine D; De Porre, Peter; Mundle, Suneel D; Small, Eric J
    Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    In: Prostate Cancer and Prostatic Diseases, Jg. 26, 2023, S. 156 – 161
    DOI (Open Access)
  • Varadi, Melinda; Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Modos, Orsolya; Szendroi, Attila; Ablat, Jason; Black, Peter C.; Keresztes, David; Csizmarik, Anita; Olah, Csilla; Gaisa, Nadine T.; Kiss, Andras; Timar, Jozsef; Toth, Erika; Csernak, Erzsebet; Gerstner, Arpad; Mittal, Vinay; Karkampouna, Sofia; Kruithof de Julio, Marianna; Gyorffy, Balazs; Bedics, Gabor; Rink, Michael; Fisch, Margit; Nyirady, Peter; Szarvas, Tibor
    Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
    In: Cancer Medicine, Jg. 12, 2023, Nr. 7, S. 9041 – 9054
    DOI (Open Access)
  • Csizmarik, Anita; Nagy, Nikolett; Keresztes, Dávid; Váradi, Melinda; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer
    In: Prostate Cancer and Prostatic Diseases, Jg. 27, 2023, Nr. 3, S. 451 – 456
    DOI (Open Access)
  • Pollock, YaoYao; Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Olmos, David; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Brendan; Brookman-May, Sabine D.; De Porre, Peter; Mundle, Suneel D.; Small, Eric J.
    Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    In: Prostate Cancer and Prostatic Diseases, Jg. 26, 2023, Nr. 4, 813
    DOI (Open Access)
  • Al-Nader, Mulham; Radtke, Jan Philipp; Püllen, Lukas; Darr, Christopher; Kesch, Claudia; Heß, Jochen; Krafft, Ulrich; Hadaschik, Boris; Harke, Nina; Mahmoud, Osama
    Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN)
    In: Journal of Robotic Surgery, Jg. 17, 2023, Nr. 5, S. 2089 – 2098
    DOI
  • Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W.; Fornara, Paolo; Kurth, Jens; Neels, O.; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J.
    DGN-Handlungsempfehlung (S1-Leitlinie) : PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms - Stand: 01/2022 - AWMF-Registernummer: 031-055
    In: Nuklearmedizin = Nuclear Medicine, Jg. 62, 2023, Nr. 1, S. 5 – 19
    DOI
  • Yirga, Leubet; Hadaschik, Boris; Püllen, Lukas
    Das Primärstaging mittels PSMA-PET verbessert die Vorhersage von Prostatakarzinomrezidiven
    In: Die Urologie, Jg. 62, 2023, Nr. 12, S. 1326 – 1327
    DOI
  • Saner, Yasemin Melisa; Wiesenfarth, Manuel; Weru, Vivienn; Ladyzhensky, Boris; Tschirdewahn, Stephan; Püllen, Lukas; Bonekamp, David; Reis, Henning; Krafft, Ulrich; Heß, Jochen A.; Kesch, Claudia; Darr, Christopher; Forsting, Michael; Wetter, Axel; Umutlu, Lale; Haubold, Johannes; Hadaschik, Boris; Radtke, Jan Philipp
    Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy : A Prospective Randomized Trial
    In: European Urology Oncology, Jg. 6, 2023, Nr. 1, S. 49 – 55
    DOI
  • Barakat, Bara; Gauger, Ulrich; Rehme, Christian; Hadaschik, Boris; Wolff, Ingmar; Hijazi, Sameh
    Diagnosis of female urethral diverticulum using pelvic floor ultrasound and comparison with voiding cystourethrogram (imaging study)
    In: International Urogynecology Journal, Jg. 34, 2023, Nr. 2, S. 563 – 569
    DOI
  • Krilaviciute, Agne; Becker, Nikolaus; Lakes, Jale; Radtke, Jan Philipp; Kuczyk, Markus; Peters, Inga; Harke, Nina N.; Debus, Jürgen; Koerber, Stefan A.; Herkommer, Kathleen; Gschwend, Jürgen E; Meissner, Valentin H.; Benner, Axel; Seibold, Petra; Kristiansen, Glen; Hadaschik, Boris; Arsov, Christian; Schimmöller, Lars; Giesel, Frederik Lars; Antoch, Gerald; Makowski, Marcus; Wacker, Frank; Schlemmer, Heinz-Peter; Kaaks, Rudolf; Albers, Peter
    Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
    In: European Urology Oncology, Jg. 6, 2023, Nr. 6, S. 566 – 573
    DOI
  • Váradi, Melinda; Horváth, Orsolya; Módos, Orsolya; Fazekas, Tamás; Grunewald, Camilla M.; Niegisch, Günter; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Olah, Csilla; Maráz, Anikó; Furka, Andrea; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice : results of a multicentric, retrospective study
    In: Scientific Reports, Jg. 13, 2023, Nr. 1, 17378
    DOI (Open Access)
  • Zschäbitz, Stefanie; Biernath, Nadine; Hilser, Thomas; Höllein, Alexander; Zengerling, Friedemann; Cascucelli, Jozefina; Paffenholz, Pia; Seidl, Daniel; Lutz, Christoph; Schlack, Katrin; Kingreen, Dorothea; Klümper, Niklas; Ivanyi, Philipp; von Amsberg, Gunhild; Heers, Hendrik; Roghmann, Florian; Tauber, Robert L.; Cathomas, Richard; Hofer, Luisa; Niegisch, Günter; Klee, Melanie; Ehrenberg, Roland; Hassler, Andreas; Hadaschik, Boris; Grünwald, Viktor; Darr, Christopher
    Enfortumab Vedotin in Metastatic Urothelial Carcinoma : Survival and Safety in a European Multicenter Real-world Patient Cohort
    In: European Urology Open Science, Jg. 53, 2023, S. 31 – 37
    DOI (Open Access)
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 711 – 716
    DOI (Open Access)
  • Pöttgen, Christoph; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago Garcia, Alina; Krafft, Ulrich; Hadaschik, Boris; Khouya, Aymane; Stuschke, Martin
    Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer : Answers from a Prospective Registry
    In: Cancers, Jg. 15, 2023, Nr. 20, 4933
    DOI (Open Access)
  • Darr, Christopher; Hilser, Thomas; Kesch, Claudia; Isgandarov, Aykhan; Reis, Henning; Wahl, Milan; Kasper-Virchow, Isabel; Hadaschik, Boris; Grünwald, Viktor
    Immune-Checkpoint-Inhibitor Therapy : Principles and Relevance of Biomarkers for Pathologists and Oncologists
    In: Advances in Anatomic Pathology, Jg. 30, 2023, Nr. 3, S. 160 – 166
    DOI
  • Darr, Christopher; Costa, Pedro Fragoso; Kahl, Theresa; Moraitis, Alexandros; Engel, Jenna; Al-Nader, Mulham; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Maurer, Tobias; Köhler, Daniel; Klutmann, Susanne; Falkenbach, Fabian; Kleesiek, Jens; Fendler, Wolfgang P.; Hadaschik, Boris; Herrmann, Ken
    Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
    In: European Urology Open Science, Jg. 54, 2023, S. 28 – 32
    DOI (Open Access)
  • Khalil, Dalia Ahmad; Wulff, Jörg; Jazmati, Danny; Geismar, Dirk; Bäumer, Christian; Kramer, Paul-Heinz; Steinmeier, Theresa; Schulze Schleithoff, Stefanie; Tschirdewahn, Stephan; Hadaschik, Boris; Timmermann, Beate
    Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? : A Dosimetric and Radiobiological Comparison Study
    In: Current Oncology, Jg. 30, 2023, Nr. 1, S. 758 – 768
    DOI, Online Volltext (Open Access)
  • Seifert, Robert; Telli, Tugce; Hadaschik, Boris; Fendler, Wolfgang; Kuo, Phillip H.; Herrmann, Ken
    Is ¹⁸F-FDG PET Needed to Assess ¹⁷⁷Lu-PSMA Therapy Eligibility? : A VISION-like, Single-Center Analysis
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 731 – 737
    DOI (Open Access)
  • Meyer, Lena; Bohlscheid, Andreas; Lemmer, Oscar; Van De Plas, Jeroen; Leboutte, Francois; Hadaschik, Boris A.; Neisius, Andreas; Willinek, Winfried A.
    MR-Guided Transurethral Ultrasound Ablation of Prostate Cancer : Initial Experience of Monitoring Tumor Response by Dynamic Apparent Diffusion Coefficient Measurements at 3.0 T
    In: Urologia Internationalis, Jg. 107, 2023, Nr. 7, S. 684 – 692
    DOI, Online Volltext (Open Access)
  • Posdzich, Philip; Darr, Christopher; Hilser, Thomas; Wahl, Milan; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Metastatic Prostate Cancer : A Review of Current Treatment Options and Promising New Approaches
    In: Cancers, Jg. 15, 2023, Nr. 2, 461
    DOI, Online Volltext (Open Access)
  • Isgandarov, A.; Darr, Christopher; Posdzich, P.; Herrmann, Ken; Hadaschik, Boris A.; Grünwald, Viktor
    Neue Therapieansätze und Studienübersicht beim metastasierten hormonsensitiven Prostatakarzinom
    In: Die Urologie, Jg. 62, 2023, Nr. 4, S. 369 – 375
    DOI
  • Pomykala, K.L.; Hadaschik, Boris; Sartor, O.; Gillessen, S.; Sweeney, C.J.; Maughan, T.; Hofman, M.S.; Herrmann, Ken
    Next generation radiotheranostics promoting precision medicine
    In: Annals of Oncology, Jg. 34, 2023, Nr. 6, S. 507 – 519
    DOI
  • Cathomas, Richard; Rothschild, Sacha I.; Hayoz, Stefanie; Bubendorf, Lukas; Özdemir, Berna C.; Kiss, Bernhard; Erdmann, Andreas; Aeppli, Stefanie; Mach, Nicolas; Strebel, Räto T; Hadaschik, Boris; Berthold, Dominik; John, Hubert; Zihler, Deborah; Schmid, Mathias; Alborelli, Ilaria; Schneider, Martina; Musilova, Jana; Spahn, Martin; Petrausch, Ulf
    Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma : Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17
    In: Journal of Clinical Oncology (JCO), Jg. 41, 2023, Nr. 33, S. 5131 – 5139
    DOI (Open Access)
  • Yirga, Leubet; Hadaschik, Boris; Burger, Maximilian; Püllen, Lukas
    Photodynamische transurethrale Resektion der Blase (TURB): mehr Schein als Sein : Ein Kommentar zur randomisierten Studie
    In: Die Urologie, Jg. 62, 2023, Nr. 2, S. 181 – 183
    DOI
  • Széles, Ádám; Fazekas, Tamás; Váncsa, Szilard; Váradi, Melinda; Kovács, Petra Terézia; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Csizmarik, Anita; Hegyi, Péter; Váradi, Alex; Nyirády, Péter; Szarvas, Tibor
    Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy : a systematic review and meta-analysis
    In: Cancer Immunology, Immunotherapy, Jg. 72, 2023, Nr. 5, S. 1061 – 1073
    DOI (Open Access)
  • Olah, Csilla; Reis, Henning; Hoffmann, Michèle J.; Mairinger, Fabian; Ting, Saskia; Hadaschik, Boris; Krafft, Ulrich; Grünwald, Viktor; Nyirady, Peter; Varadi, Melinda; Győrffy, Balázs; Kiss, Andras; Szekely, Eszter; Sjödahl, Gottfrid; Szarvas, Tibor
    Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
    In: Cancer Medicine, Jg. 12, 2023, Nr. 5, S. 5222 – 5232
    DOI, Online Volltext (Open Access)
  • Deivasigamani, Sriram; Kotamarti, Srinath; Rastinehad, Ardeshir R.; Sanchez Salas, Rafael; de la Rosette, J.J.M.C.H.; Lepor, Herbert; Pinto, Peter; Ahmed, Hashim U.; Gill, Inderbir; Klotz, Laurence; Taneja, Samir S.; Emberton, Mark; Lawrentschuk, Nathan; Wysock, James; Feller, John F.; Crouzet, Sebastien; Kumar M., Praveen; Seguier, Denis; Adams, Eric S.; Michael, Zoe; Abreu, Andre; Jack Tay, Kae; Ward, John F.; Shinohara, Katsuto; Katz, Aaron E.; Villers, Arnauld; Chin, Joseph L.; Stricker, Phillip D.; Baco, Eduard; Macek, Petr; Ahmad, Ardalan E.; Chiu, Peter K.F.; Crawford, E. David; Rogers, Craig G.; Futterer, Jurgen J.; Rais-Bahrami, Soroush; Robertson, Cary N.; Hadaschik, Boris; Marra, Giancarlo; Valerio, Massimo; Chong, Kian Tai; Kasivisvanathan, Veeru; Tan, Wei Phin; Lomas, Derek; Walz, Jochen; Guimaraes, Gustavo Cardoso; Mertziotis, Nikos I.; Becher, Ezequiel; Finelli, Antonio; Kasraeian, Ali; Lebastchi, Amir H.; Vora, Anup; Rosen, Mark A.; Bakir, Baris; Arcot, Rohit; Yee, Samuel; Netsch, Christopher; Meng, Xiaosong; de Reijke, Theo M.; Tan, Yu Guang; Regusci, Stefano; Benjamin, Tavya G.R.; Olivares, Ruben; Noureldin, Mohamed; Bianco, Fernando J.; Sivaraman, Arjun; Kim, Fernando J.; Given, Robert W.; Dason, Shawn; Sheetz, Tyler J.; Shoji, Sunao; Schulman, Ariel; Royce, Peter; Shah, Taimur T.; Scionti, Stephen; Salomon, Georg; Laguna, Pilar; Tourinho-Barbosa, Rafael; Aminsharifi, Alireza; Cathelineau, Xavier; Gontero, Paolo; Stabile, Armando; Grummet, Jeremy; Ledbetter, Leila; Graton, Margaret; Jones, J. Stephen; Polascik, Thomas J.
    Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer : A Focal Therapy Society Best Practice Statement
    In: European Urology, Jg. 84, 2023, Nr. 6, S. 547 – 560
    DOI, Online Volltext (Open Access)
  • Maier, Daniel; Vehreschild, Jörg Janne; Uhl, Barbara; Meyer, Sandra; Berger-Thürmel, Karin; Boerries, Melanie; Braren, Rickmer; Grünwald, Viktor; Hadaschik, Boris; Palm, Stefan; Singer, Susanne; Stuschke, Martin; Juárez, David; Delpy, Pierre; Lambarki, Mohamed; Hummel, Michael; Engels, Cäcilia; Andreas, Stefanie; Gökbuget, Nicola; Ihrig, Kristina; Burock, Susen; Keune, Dietmar; Eggert, Angelika; Keilholz, Ulrich; Schulz, Hagen; Büttner, Daniel; Löck, Steffen; Krause, Mechthild; Esins, Mirko; Ressing, Frank; Schuler, Martin; Brandts, Christian; Brucker, Daniel P.; Husmann, Gabriele; Oellerich, Thomas; Metzger, Patrick; Voigt, Frederik; Illert, Anna L.; Theobald, Matthias; Kindler, Thomas; Sudhof, Ursula; Reckmann, Achim; Schwinghammer, Felix; Nasseh, Daniel; Weichert, Wilko; von Bergwelt-Baildon, Michael; Bitzer, Michael; Malek, Nisar; Öner, Öznur; Schulze-Osthoff, Klaus; Bartels, Stefan; Haier, Jörg; Ammann, Raimund; Schmidt, Anja Franziska; Guenther, Bernd; Janning, Melanie; Kasper, Bernd; Loges, Sonja; Stilgenbauer, Stephan; Kuhn, Peter; Tausch, Eugen; Runow, Silvana; Kerscher, Alexander; Neumann, Michael; Breu, Martin; Lablans, Martin; Serve, Hubert
    Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
    In: European Journal of Epidemiology, Jg. 38, 2023, Nr. 5, S. 573 – 586
    DOI (Open Access)
  • Klümper, Niklas; Eckstein, Markus; Hölzel, Michael; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Re: First-in-Human Study of the Radioligand ⁶⁸Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma : Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT
    In: European Urology, Jg. 84, 2023, Nr. 5, S. 514 – 515
    DOI
  • Gafita, Andrei; Djaileb, Loïc; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea
    Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
    In: Radiology, Jg. 308, 2023, Nr. 1, e222148
    DOI, Online Volltext (Open Access)
  • Kesch, Claudia; Pantea, Vlad; Soeterik, Timo; Marquis, Alessandro; la Bombarda, Giulia; Morlacco, Allesandro; Barletta, Francesco; Radtke, Jan Philipp; Darr, Christopher; Preisser, Felix; Zattoni, Fabio; Marra, Giancarlo; van den Bergh, Roderik C. N.; Hadaschik, Boris; Gandaglia, Giorgio
    Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy : a multicenter analysis
    In: World Journal of Urology, Jg. 41, 2023, Nr. 2, S. 427 – 434
    DOI (Open Access)
  • Seifert, Robert; Emmett, Louise; Rowe, Steven P.; Herrmann, Ken; Hadaschik, Boris; Calais, Jeremie; Giesel, Frederik L.; Reiter, Robert; Maurer, Tobias; Heck, Matthias; Gafita, Andrei; Morris, Michael J.; Fanti, Stefano; Weber, Wolfgang A.; Hope, Thomas A.; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    In: European Urology, Jg. 83, 2023, Nr. 5, S. 405 – 412
    DOI (Open Access)
  • Fortuin, Ansje; van Asten, Jack; Veltien, Andor; Philips, Bart; Hambrock, Thomas; Johst, Sören; Orzada, Stephan; Hadaschik, Boris; Quick, Harald; Barentsz, Jelle; Maas, Marnix; Scheenen, Tom
    Small Suspicious Lymph Nodes Detected on Ultrahigh-field Magnetic Resonance Imaging (MRI) in Patients with Prostate Cancer with High Risk of Nodal Metastases : The First In-patient Study on Ultrasmall Superparamagnetic Iron Oxide-enhanced 7T MRI
    In: European Urology, Jg. 83, 2023, Nr. 4, S. 375 – 377
    DOI
  • Seifert, Robert; Gafita, Andrei; Telli, Tugce; Voter, Andrew; Herrmann, Ken; Pomper, Martin; Hadaschik, Boris; Rowe, Steven P.; Fendler, Wolfgang
    Standardized PSMA-PET Imaging of Advanced Prostate Cancer
    In: Seminars in Nuclear Medicine, Jg. 54, 2023, Nr. 1, S. 60 – 68
    DOI
  • Handke, Analena Elisa; Albers, Peter; Schimmöller, Lars; Bonekamp, David; Asbach, Patrick; Schlemmer, Heinz-Peter; Hadaschik, Boris; Radtke, Jan Philipp
    Systematische oder gezielte Fusionsbiopsie der Prostata
    In: Die Urologie, Jg. 62, 2023, Nr. 5, S. 464 – 472
    DOI
  • Fazekas, Tamás; Széles, Ádám D.; Teutsch, Brigitta; Csizmarik, Anita; Vékony, Bálint; Váradi, Alex; Kói, Tamás; Lang, Zsolt; Ács, Nándor; Kopa, Zsolt; Hegyi, Péter; Hadaschik, Boris; Grünwald, Viktor; Nyirády, Péter; Szarvas, Tibor
    Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients : A systematic review and meta-analysis
    In: Prostate Cancer and Prostatic Diseases, Jg. 26, 2023, Nr. 4, S. 665 – 672
    DOI (Open Access)
  • Seifert, Robert; Telli, Tugce; Opitz, Marcel; Barbato, Francesco; Berliner, Christoph; Nader, Michael; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang
    Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 738 – 743
    DOI (Open Access)
  • Olah, Csilla; Hahnen, Christina; Nagy, Nikolett; Musial, Joanna; Varadi, Melinda; Nyiro, Gabor; Gyorffy, Balazs; Hadaschik, Boris; Rawitzer, Josefine; Ting, Saskia; Sjödahl, Gottfrid; Hoffmann, Michéle J.; Reis, Henning; Szarvas, Tibor
    A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genes
    In: International Journal of Cancer, Jg. 150, 2022, Nr. 5, S. 856 – 867
    DOI (Open Access)
  • Arsov, Christian; Albers, Peter; Herkommer, Kathleen; Gschwend, Jürgen; Imkamp, Florian; Peters, Inga; Kuczyk, Markus; Hadaschik, Boris; Kristiansen, Glen; Schimmöller, Lars; Antoch, Gerald; Rummeny, Ernst; Wacker, Frank; Schlemmer, Heinz; Benner, Axel; Siener, Roswitha; Kaaks, Rudolf; Becker, Nikolaus
    A randomized trial of risk-adapted screening for prostate cancer in young men : Results of the first screening round of the PROBASE trial
    In: International Journal of Cancer, Jg. 150, 2022, Nr. 11, S. 1861 – 1869
    DOI (Open Access)
  • Chowdhury, Simon; Oudard, Stephane; Uemura, Hiroji; Joniau, Steven; Dearden, Lindsay; Capone, Camille; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris A.
    Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer : Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
    In: Advances in Therapy, Jg. 39, 2022, Nr. 1, S. 518 – 531
    DOI (Open Access)
  • Chowdhury, Simon; Oudard, S.; Uemura, H.; Joniau, S.; Dearden, L.; Capone, C.; van Sanden, S.; Diels, J.; Hadaschik, Boris
    Apalutamide compared with darolutamide for the treatment of non-metastatic castration resistant prostate cancer : efficacy and tolerability in a matching-adjusted indirect comparison
    In: Onkourologija (= Cancer Urology), Jg. 18, 2022, Nr. 1, S. 77 – 89
    DOI (Open Access)
  • Deutsch, Sebastian; Hadaschik, Boris; Lebentrau, Steffen; Ubrig, Burkhard; Burger, Max; May, Matthias
    Clinical Importance of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection : A Systematic Review and Meta-Analysis
    In: Urologia Internationalis, Jg. 106, 2022, Nr. 1, S. 28 – 34
    DOI (Open Access)
  • Rehme, Christian R.; Fritsch, Beatrix; Thomas, Luca; Istin, Stefan; Burchert, Carolin; Hummel, Bastian; Baleanu-Curaj, Bogdan; Reis, Henning; Szarvas, Tibor; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patients
    In: International Urology and Nephrology, Jg. 54, 2022, Nr. 1, S. 71 – 79
    DOI (Open Access)
  • Krafft, Ulrich; Mahmoud, O.; Heß, Jochen A.; Radtke, Jan Phillipp; Panic, Andrej; Püllen, Lukas; Darr, Christopher; Kesch, C.; Szarvas, Tibor; Rehme, Christian R.; Hadaschik, Boris; Tschirdewahn, Stephan
    Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture
    In: Langenbeck's Archives of Surgery, Jg. 407, 2022, Nr. 3, S. 1233 – 1240
    DOI (Open Access)
  • Keresztes, Dávid; Csizmarik, Anita; Nagy, Nikolett; Módos, Orsolya; Fazekas, Tamás; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Sevcenco, Sabina; Kramer, Gero; Shariat, Shahrokh; Küronya, Zsófia; Takács, László; Tornyi, Ilona; Lázár, József; Hadaschik, Boris; Lászik, András; Szűcs, Miklós; Nyirády, Péter; Szarvas, Tibor
    Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer
    In: Journal of Cellular and Molecular Medicine, Jg. 26, 2022, Nr. 4, S. 1332 – 1337
    DOI (Open Access)
  • Barakat, Bara; Franke, Knut; Hijazi, Sameh; Wolff, Ingmar; Hadaschik, Boris; Rehme, Christian R.
    Correlation between symptoms and imaging findings including pelvic floor ultrasound to improve the symptom-based diagnosis of female urethral diverticulum (CHECK-UD study)
    In: International Urogynecology Journal, Jg. 33, 2022, Nr. 8, S. 2267 – 2274
    DOI
  • Saad, Fred; Small, Eric J.; Feng, Felix Y.; Graff, Julie N.; Olmos, David; Hadaschik, Boris; Oudard, Stéphane; Londhe, Anil; Bhaumik, Amitabha; Lopez-Gitlitz, Angela; Thomas, Shibu; Mundle, Suneel D.; Chowdhury, Simon; Smith, Matthew R.
    Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN
    In: European Urology, Jg. 81, 2022, Nr. 2, S. 184 – 192
    DOI (Open Access)
  • Ahmad Khalil, Dalia; Jazmati, Danny; Geismar, Dirk; Wulff, Jörg; Bäumer, Christian; Kramer, Paul Heinz; Steinmeier, Theresa; Schulze Schleithoff, Stefanie; Plaude, Sandija; Bischoff, Martin; Tschirdewahn, Stephan; Hadaschik, Boris; Timmermann, Beate
    Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
    In: Radiation Oncology, Jg. 17, 2022, Nr. 1, 64
    DOI, Online Volltext (Open Access)
  • Fanti, Stefano; Briganti, Alberto; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Kunikowska, Jolanta; Maurer, Tobias; MacLennan, Steven; Mottet, Nicolas; Murphy, Declan G.; Oprea-Lager, Daniela E.; O'Sullivan, Joe M.; Oyen, Wim J G; Rouvière, Olivier; Sartor, Oliver; Stenzl, Arnulf; Van Poppel, Hendrik; Walz, Jochen; Witjes, Wim; Bjartell, Anders
    EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy
    In: European Urology Oncology, Jg. 5, 2022, Nr. 5, S. 530 – 536
    DOI (Open Access)
  • Kovács, Petra Terézia; Mayer, Tamás; Csizmarik, Anita; Váradi, Melinda; Oláh, Csilla; Széles, Ádám; Tschirdewahn, Stephan; Krafft, Ulrich; Hadaschik, Boris; Nyirády, Péter; Riesz, Péter; Szarvas, Tibor
    Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines, Jg. 10, 2022, Nr. 3, 698
    DOI, Online Volltext (Open Access)
  • Oudard, Stéphane; Hadaschik, Boris; Saad, Fred; Cella, David; Basch, Ethan; Graff, Julie N.; Uemura, Hiroji; Dibaj, Shiva; Li, Susan; Brookman-May, Sabine D.; De Porre, Peter; Bevans, Katherine B.; Trudeau, Jeremiah J.; Small, Eric J.; Smith, Matthew R.
    Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    In: European Urology Focus, Jg. 8, 2022, Nr. 4, S. 958 – 967
    DOI (Open Access)
  • Széles, Ádám; Kovács, Petra Terézia; Csizmarik, Anita; Váradi, Melinda; Riesz, Péter; Fazekas, Tamás; Váncsa, Szilárd; Hegyi, Péter; Oláh, Csilla; Tschirdewahn, Stephan; Darr, Christopher; Krafft, Ulrich; Grünwald, Viktor; Hadaschik, Boris; Horváth, Orsolya; Nyirády, Péter; Szarvas, Tibor
    High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
    In: Biomedicines, Jg. 10, 2022, Nr. 10, 2560
    DOI (Open Access)
  • Struck, Julian P.; Schnoor, Maike; Schulze, Andrea; Hupe, Marie C.; Ozimek, Tomasz; Oppolzer, Immanuel A.; Schnabel, Marco J.; Burger, Maximilian; Darr, Christopher; Gruenwald, Viktor; Hadaschik, Boris; Weinke, Maximilian; Kuebler, Hubert; Klockenbusch, Jonas C.; Grabbert, Markus T.; Gratzke, Christian; Kramer, Mario W.; Katalinic, Alexander; Merseburger, Axel S.
    Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy : a multicenter study in German university hospitals
    In: World Journal of Urology, Jg. 40, 2022, Nr. 2, S. 409 – 418
    DOI (Open Access)
  • Harke, Nina; Kuczyk, Markus A.; Huusmann, Stephan; Schiefelbein, Frank; Schneller, Andreas; Schoen, Georg; Wiesinger, Clemens; Pfuner, Jacob; Ubrig, Burkhard; Gloger, Simon; Osmonov, Daniar; Eraky, Ahmed; Witt, Jörn H.; Liakos, Nikolaos; Wagner, Christian; Hadaschik, Boris; Radtke, Jan-Philipp; Al Nader, Mulham; Imkamp, Florian; Siemer, Stefan; Stöckle, Michael; Zeuschner, Philip
    Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes : A Multicenter Analysis of 2500 Patients
    In: European Urology Open Science, Jg. 46, 2022, S. 45 – 52
    DOI (Open Access)
  • Ohlmann, Carsten; Grünwald, Viktor; Hadaschik, Boris
    Kombinierte Hormontherapie beim lokal begrenzten Prostatakarzinom
    In: Die Urologie, Jg. 61, 2022, Nr. 9, S. 660 – 662
    DOI
  • Harke, Nina; Wagner, Christian; Hermann, Robert M.; Hadaschik, Boris; Radtke, Jan Philipp; Altay-Langguth, Alev; Aufderklamm, Stefan; Bach, Christian; Becker-Schiebe, Martina; Blana, Andreas; Bruns, Frank; Buse, Stephan; Combs, Stephanie E.; Engels, Christina L.; Ezzibdeh, Emad; Fiedler, Marcel; Fischer, Laura-Anna; Farzat, Mahmoud; Frismann, Alexander; Heck, Matthias M.; Henkenberens, Christoph; Roesch, Marie C.; Kading, Christoph; Klautke, Gunther; Krausewitz, Philipp; Kuczyk, Markus A.; Leitsmann, Conrad; Lettmaier, Sebastian; Mahjoub, Samy; Manseck, Andreas; Medenwald, Daniel; Meyer, Andreas; Micke, Oliver; Moritz, Rudolf; Ott, Marcel; Peters, Inga; Pokupic, Sasa; Porres, Daniel; Preisser, Felix; Reichel, Kathrin; Schneider, Andreas; Schwentner, Christian; Scobioala, Sergiu; Truss, Michael; Wegener, Daniel; Wezel, Felix; Willborn, Kay; Witt, Jorn H.; Wittig, Andrea; Wittlinger, Michael; Wolff, Hendrik A.; Zimmermanns, Volker; Christiansen, Hans
    Lessons learned after one year of COVID-19 from a urologist and radiotherapist view : A German survey on prostate cancer diagnosis and treatment
    In: PLoS ONE, Jg. 17, 2022, Nr. 6, e0269827
    DOI (Open Access)
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0) : An International Multicenter Study
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 11, S. 1651 – 1658
    DOI (Open Access)
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Onkologie, Jg. 28, 2022, Nr. 7, S. 612 – 622
    DOI
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Radiologie, Jg. 62, 2022, Nr. 10, S. 875 – 884
    DOI
  • Wessolly, Michael; Mairinger, Fabian D.; Herold, Thomas; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
    In: Genes, Jg. 13, 2022, Nr. 3, 422
    DOI (Open Access)
  • Csizmarik, Anita; Keresztes, Dávid; Nagy, Nikolett; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Jurányi, Zsolt; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor
    Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer
    In: International Journal of Cancer, Jg. 151, 2022, Nr. 8, S. 1405 – 1419
    DOI (Open Access)
  • Costa, Pedro Fragoso; Fendler, Wolfgang; Herrmann, Ken; Sandach, Patrick; Grafe, Hong; Grootendorst, Maarten R.; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Radtke, Jan P.; Tschirdewahn, Stephan; Hadaschik, Boris; Darr, Christopher
    Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 9, S. 1349 – 1356
    DOI (Open Access)
  • Grünwald, Viktor; Ohlmann, Carsten-Henning; Hadaschik, Boris
    Re: Abiraterone Acetate and Prednisolone With or Without Enzalutamide for High-risk Non-metastatic Prostate Cancer : A Meta-analysis of Primary Results from Two Randomized Controlled Phase 3 Trials of the STAMPEDE Platform Protocol
    In: European Urology, Jg. 81, 2022, Nr. 6, S. 621
    DOI
  • Kesch, Claudia; Hadaschik, Boris
    Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer : The ENACT Randomized Clinical Trial
    In: European Urology, Jg. 82, 2022, Nr. 5, S. 572
    DOI
  • Seifert, Robert; Sandach, Patrick; Kersting, David; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Sunderland, John J.; Pollard, Janet H.
    Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 5, S. 746 – 753
    DOI (Open Access)
  • Barakat, Bara; Rehme, Christian R.; Hadaschik, Boris
    Reply to Nikolaos Grivas, Nikolaos Kalampokis, Markos Karavitakis, Ioannis Leotsakos, Ioannis Katafigiotis, and Henk van der Poel’s Letter to the Editor re: Bara Barakat, Hazem Othman, Ulrich Gauger, Ingmar Wolff, Boris Hadaschik, Christian Rehme. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.08.003
    In: European Urology Focus, Jg. 8, 2022, Nr. 5, S. 1556
    DOI
  • Püllen, Lukas; Kaspar, Cordelia; Panic, Andrej; Heß, Jochen A.; Reis, Henning; Szarvas, Tibor; Radtke, Jan Philipp; Krafft, Ulrich; Darr, Christopher; Hadaschik, Boris; Tschirdewahn, Stephan
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre Cohort
    In: Urologia Internationalis, Jg. 106, 2022, S. 638 – 643
    DOI
  • Barakat, Bara; Othman, Hazem; Gauger, Ulrich; Wolff, Ingmar; Hadaschik, Boris; Rehme, Christian R.
    Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy : Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis
    In: European Urology Focus, Jg. 8, 2022, Nr. 4, S. 1060 – 1071
    DOI
  • Reis, Henning; Skottky, Silke; Hager, Thomas; Hadaschik, Boris; Waue, Veronika; Zwönitzer, Ralf
    Strukturierte Befundung am Beispiel des Prostatakarzinoms  : Selbstentwicklung einer digitalen Lösung für Prostatastanzbiopsien
    In: Die Pathologie, Jg. 43, 2022, Nr. Suppl. 1, S. 94 – 100
    DOI
  • Ingenwerth, Marc; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor; Reis, Henning
    The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer
    In: Current Molecular Medicine, Jg. 22, 2022, Nr. 10, S. 941 – 949
    DOI
  • Darr, Christopher; Finis, Friederike; Wiesenfarth, Manuel; Giganti, Francesco; Tschirdewahn, Stephan; Krafft, Ulrich; Kesch, Claudia; Bonekamp, David; Forsting, Michael; Wetter, Axel; Reis, Henning; Hadaschik, Boris; Haubold, Johannes; Radtke, Jan Philipp
    Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy : A Feasibility Study
    In: European Urology Oncology, Jg. 5, 2022, Nr. 3, S. 357 – 361
    DOI, Online Volltext (Open Access)
  • Murray, Jacob M.; Wiegand, Bodo; Hadaschik, Boris; Herrmann, Ken; Kleesiek, Jens
    Virtual Biopsy : Just an AI Software or a Medical Procedure?
    In: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 4, S. 511 – 513
    DOI, Online Volltext (Open Access)
  • Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Graff, Julie N.; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; De Porre, Peter; Smith, Andressa A.; Brookman-May, Sabine D.; Li, Susan; Zhang, Ke; Rooney, Brendan; Lopez-Gitlitz, Angela; Small, Eric J.
    Apalutamide and Overall Survival in Prostate Cancer
    In: European Urology, Jg. 79, 2021, Nr. 1, S. 150 – 158
    DOI (Open Access)
  • Feng, Felix Y.; Thomas, Shibu; Saad, Fred; Gormley, Michael; Yu, Margaret K.; Ricci, Deborah S.; Rooney, Brendan; Brookman-May, Sabine; McCarthy, Sharon; Olmos, David; Chowdhury, Simon; Hadaschik, Boris; Liu, Yang; Davicioni, Elai; Smith, Matthew R.; Small, Eric J.
    Association of molecular subtypes with differential outcome to apalutamide treatment in nonmetastatic castration-resistant prostate cancer
    In: JAMA Oncology, Jg. 7, 2021, Nr. 7, S. 1005 – 1014
    DOI (Open Access)
  • Collamati, Francesco; van Oosterom, Matthias N.; Hadaschik, Boris; Fragoso Costa, Pedro; Darr, Christopher
    Beta radioguided surgery: towards routine implementation?
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 65, 2021, Nr. 3, S. 229 – 243
    DOI
  • Krafft, Ulrich; Hirner, C.; Hirner (L.), Lucas; Darr, Christopher; Mahmoud, O.; Hadaschik, Boris; Rehme, Christian R.
    Botulinum Toxin A in Pediatric Day-Time Lower Urinary Tract Conditions : A Single Center Experience
    In: Journal of Urology and Renal Diseases, Jg. 6, 2021, Nr. 6, 1236
    DOI (Open Access)
  • Szarvas, Tibor; Csizmarik, Anita; Fazekas, Tamás; Hüttl, András; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Püllen, Lukas; Jurányi, Zsolt; Kocsis, Zsuzsa; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnieszka; Kramer, Gero
    Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer
    In: BJU International (BJUI), Jg. 127, 2021, Nr. 1, S. 44 – 55
    DOI
  • Fanti, Stefano; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Maurer, Tobias; MacLennan, Steven; Oprea-Lager, Daniela E.; Oyen, Wim Jg; Rouvière, Olivier; Mottet, Nicolas; Bjartell, Anders
    Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 2, S. 469 – 476
    DOI (Open Access)
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    Correction to : COVID-19 research ; promising tracks leading to uro-oncology
    In: International Urology and Nephrology, Jg. 53, 2021, Nr. 1, S. 95
    DOI (Open Access)
  • Tschirdewahn, Stephan; Wiesenfarth, Manuel; Bonekamp, David; Püllen, Lukas; Reis, Henning; Panic, Andrej; Kesch, Claudia; Darr, Christopher; Heß, Jochen A.; Giganti, Francesco; Moore, Caroline M.; Guberina, Nika; Forsting, Michael; Wetter, Axel; Hadaschik, Boris; Radtke, Jan Philipp
    Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy
    In: European Urology Focus, Jg. 7, 2021, Nr. 6, S. 1300 – 1307
    DOI, Online Volltext (Open Access)
  • Roth, Rebecca; Dieng, Sebastian; Oesterle, Alisa; Feick, Günter; Carl, Günther; Hinkel, Andreas; Steiner, Thomas; Kaftan, Björn Theodor; Kunath, Frank; Hadaschik, Boris; Oostdam, Simba-Joshua; Palisaar, Rein Jüri; Koralewski, Mateusz; Beyer, Burkhard; Haben, Björn; Tsaur, Igor; Wesselmann, Simone; Kowalski, Christoph
    Determinants of self-reported functional status (EPIC-26) in prostate cancer patients prior to treatment
    In: World Journal of Urology, Jg. 39, 2021, Nr. 1, S. 27 – 36
    DOI (Open Access)
  • Scharl, S.; Hadaschik, Boris; Wiegel, T.; Thomas, C.
    Die Therapie des primär oligometastasierten Prostatakarzinoms
    In: Der Urologe, Jg. 60, 2021, Nr. 12, S. 1527 – 1533
    DOI
  • Staniszewska, Magdalena; Iking, Janette; Lückerath, Katharina; Hadaschik, Boris; Herrmann, Ken; Ferdinandus, Justin; Fendler, Wolfgang
    Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
    In: Nuclear Medicine and Biology, Jg. 96-97, 2021, S. 101 – 111
    DOI (Open Access)
  • Stuschke, Martin; Hadaschik, Boris
    Elektive Strahlentherapie pelviner Lymphknoten beim High-risk-Prostatakarzinom? : Bewertung der Relation zwischen der relativen Risikoreduktion eines PSA-Rezidivs (prostataspezifisches Antigen) innerhalb von 5 Jahren und einem absoluten Überlebensvorteil
    In: Der Urologe, Jg. 60, 2021, Nr. 8, S. 1051 – 1053
    DOI
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 14, 7431
    DOI, Online Volltext (Open Access)
  • Kesch, Claudia; Yirga, Leubet; Dendl, Katharina; Handke, Analena; Darr, Christopher; Krafft, Ulrich; Radtke, Jan Philipp; Tschirdewahn, Stephan; Szarvas, Tibor; Fazli, Ladan; Gleave, Martin; Giesel, Frederik L.; Haberkorn, Uwe; Hadaschik, Boris
    High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2021, S. 385 – 389
    DOI (Open Access)
  • Krafft, Ulrich; Olah, Csilla; Reis, Henning; Kesch, Claudia; Darr, Christopher; Grünwald, Viktor; Tschirdewahn, Stephan; Hadaschik, Boris; Horvath, Orsolya; Kenessey, Istvan; Nyirady, Peter; Varadi, Melinda; Modos, Orsolya; Csizmarik, Anita; Szarvas, Tibor
    High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapy
    In: Cancers, Jg. 13, 2021, Nr. 11, 2548
    DOI, Online Volltext (Open Access)
  • Schaudinn, Alexander; Michaelis, Jakob; Franz, Toni; Ho-Thi, Phuc; Horn, Lars-Christian; Blana, Andreas; Hadaschik, Boris; Stumpp, Patrick; Stolzenburg, Jens-Uwe; Schlemmer, Heinz–Peter; Denecke, Timm; Busse, Harald; Ganzer, Roman; Linder, Nicolas
    High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients
    In: European Journal of Radiology, Jg. 144, 2021, 109957
    DOI
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Herrmann, Ken; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Fendler, Wolfgang
    Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 5, S. 675 – 678
    DOI (Open Access)
  • Berrens, Anne-Claire; van Leeuwen, Pim J.; Maurer, Tobias; Hadaschik, Boris; Krafft, Ulrich
    Implementation of radioguided surgery in prostate cancer
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 65, 2021, Nr. 3, S. 202 – 214
    DOI
  • Handke, Analena Elisa; Graefen, Markus; Ullrich, Tim; Wibmer, Andreas; Hadaschik, Boris; Giganti, Francesco; Schimmöller, Lars; Radtke, Jan Philipp
    Kann die Progression eines Prostatakarzinoms während Active Surveillance durch serielle Magnetresonanztomographie verlässlich diagnostiziert werden?
    In: Der Urologe, Jg. 60, 2021, Nr. 12, S. 1594 – 1597
    DOI
  • Stuschke, Martin; Hadaschik, Boris
    Lokale Strahlentherapie der Prostata mit Samenblasenbasis allein oder mit elektiver Bestrahlung pelviner Lymphknotenstationen beim Hochrisiko-Prostatakarzinom? : Ergebnisse der randomisierten POP-RT-Studie
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 197, 2021, Nr. 10, S. 939 – 942
    DOI (Open Access)
  • Püllen, Lukas; Sprave, Tanja; Hadaschik, Boris; Wiegel, Thomas
    Lokale und Metastasen-gerichtete Therapieoptionen beim oligometastasierten Prostatakarzinom
    In: Aktuelle Urologie, Jg. 52, 2021, Nr. 2, S. 149 – 154
    DOI
  • Heß-Busch, Yasmine; Hadaschik, Boris; Heß, Jochen A.
    M0CRPC overview of management options
    In: World Journal of Urology, Jg. 39, 2021, Nr. 2, S. 349 – 356
    DOI
  • Szarvas, Tibor; Hoffmann, Michèle J.; Olah, Csilla; Szekely, Eszter; Kiss, Andras; Hess, Jochen; Tschirdewahn, Stephan; Hadaschik, Boris; Grotheer, Vera; Nyirady, Peter; Csizmarik, Anita; Varadi, Melinda; Reis, Henning
    MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
    In: Diagnostics, Jg. 11, 2021, Nr. 1, 48
    DOI, Online Volltext (Open Access)
  • Csizmarik, Anita; Hadaschik, Boris; Kramer, Gero; Nyirady, Peter; Szarvas, Tibor
    Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 39, 2021, Nr. 10, S. 728.e13 – 728.e24
    DOI (Open Access)
  • Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R.; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R.; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B.; Delpassand, Ebrahim S.; Haberkorn, Uwe; Elashoff, David; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective study
    In: The Lancet Oncology, Jg. 22, 2021, Nr. 8, S. 1115 – 1125
    DOI (Open Access)
  • Herrmann, Ken; Kraus, Bernd Joachim; Hadaschik, Boris; Kunikowska, Jolanta; van Poppel, Hendrik; N'Dow, James; Sartor, Oliver; Oyen, Wim J. G.
    Nuclear medicine theranostics comes of age
    In: The Lancet Oncology, Jg. 22, 2021, Nr. 11, S. 1497 – 1498
    DOI
  • Seifert, Robert; Kessel, Katharina; Schlack, Katrin; Weber, Manuel; Herrmann, Ken; Spanke, Maximilian; Fendler, Wolfgang; Hadaschik, Boris; Kleesiek, Jens; Schäfers, Michael; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz
    PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 48, 2021, Nr. 4, S. 1200 – 1210
    DOI (Open Access)
  • Barbato, Francesco; Fendler, Wolfgang; Rauscher, Isabel; Herrmann, Ken; Wetter, Axel; Ferdinandus, Justin; Seifert, Robert; Nader, Michael; Rahbar, Kambiz; Hadaschik, Boris; Eiber, Matthias; Gafita, Andrei; Weber, Manuel
    PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1747 – 1750
    DOI (Open Access)
  • Weber, Manuel; Kurek, Claudia Ewa; Barbato, Francesco; Eiber, Matthias; Maurer, Tobias; Nader, Michael; Hadaschik, Boris; Grünwald, Viktor; Herrmann, Ken; Wetter, Axel; Fendler, Wolfgang P.
    PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center study
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 1, S. 88 – 91
    DOI (Open Access)
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang P.
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocol
    In: BMC Cancer, Jg. 21, 2021, 512
    DOI (Open Access)
  • Farolfi, Andrea; Hadaschik, Boris; Hamdy, Freddie C.; Herrmann, Ken; Hofman, Michael S.; Murphy, Declan G.; Ost, Piet; Padhani, Anwar R.; Fanti, Stefano
    Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic Review
    In: European Urology Oncology, Jg. 4, 2021, Nr. 5, S. 714 – 730
    DOI
  • Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan
    Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls
    In: Translational Andrology and Urology, Jg. 10, 2021, Nr. 10, S. 3972 – 3985
    DOI (Open Access)
  • Hadaschik, Boris; Giesel, Frederik L.; Chi, Kim
    Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
    In: European Urology Focus, Jg. 7, 2021, Nr. 2, S. 229 – 230
    DOI
  • Weber, Manuel; Hadaschik, Boris; Ferdinandus, Justin; Rahbar, Kambiz; Bögemann, Martin; Herrmann, Ken; Fendler, Wolfgang; Kesch, Claudia
    Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate Cancer
    In: European Urology Focus, Jg. 7, 2021, Nr. 2, S. 279 – 287
    DOI
  • Hadaschik, Boris; Herrmann, Ken
    Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    In: European Urology, Jg. 80, 2021, Nr. 4, S. 520 – 521
    DOI
  • Grünwald, Viktor; Hadaschik, Boris
    Re: Nivolumab plus Cabozantinib Versus Sunitinib for Advanced Renal-cell Carcinoma
    In: European Urology, Jg. 80, 2021, Nr. 2, S. 256 – 257
    DOI
  • Radtke, Jan Philipp; Nyarangi-Dix, Joanne; Wiesenfarth, Manuel; Hadaschik, Boris
    Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy
    In: European Urology, Jg. 79, 2021, Nr. 1, S. 164 – 165
    DOI
  • Harke, Nina N.; Darr, Christopher; Radtke, Jan Philipp; von Ostau, Nicola; Schiefelbein, Frank; Eraky, Ahmed; Hamann, Claudius; Szarvas, Tibor; Hadaschik, Boris; Tropmann-Frick, Marina; Juenemann, Klaus-Peter; Schoen, Georg; Osmonov, Daniar
    Retroperitoneal Versus Transperitoneal Robotic Partial Nephrectomy : A Multicenter Matched-pair Analysis
    In: European Urology Focus, Jg. 7, 2021, Nr. 6, S. 1363 – 1370
    DOI
  • Rehme, Christian R.; Burchert, Carolin; Tosun, Mustafa; Szarvas, Tibor; Nagy, Nadine; Rübben, Herbert; Hadaschik, Boris; Niedworok, Christian
    Stone extraction with loop ureteral catheter versus ureteroscopy in small distal ureteral stones—retrospective comparison of 547 consecutive patients
    In: Translational Andrology and Urology, Jg. 10, 2021, Nr. 1, S. 87 – 95
    DOI (Open Access)
  • Harke, Nina Natascha; Wagner, Christian; Liakos, Nikolaos; Urbanova, Katarina; Addali, Mustapha; Hadaschik, Boris; Witt, Jorn H.
    Superior early and long-term continence following early micturition on day 2 after robot-assisted radical prostatectomy : A randomized prospective trial
    In: World Journal of Urology, Jg. 39, 2021, Nr. 3, S. 771 – 777
    DOI
  • Panic, Andrej; Reis, Henning; Wittka, Alina; Darr, Christopher; Hadaschik, Boris; Jendrossek, Verena; Klein, Diana
    The Biomarker Potential of Caveolin-1 in Penile Cancer
    In: Frontiers in Oncology, Jg. 11, 2021, S. 606122
    DOI, Online Volltext (Open Access)
  • Szarvas, Tibor; Csizmarik, Anita; Váradi, M.; Fazekas, Tamás; Hüttl, András Béla; Nyirády, Péter; Hadaschik, Boris; Grünwald, Viktor; Tschirdewahn, Stephan; Shariat, Shahrokh F.; Sevcenco, Sabina; Maj-Hes, Agnes B.; Kramer, Gero
    The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 39, 2021, Nr. 5, S. 296.e11 – 296.e19
    DOI (Open Access)
  • Hirner, Lucas; Rübben, Iris; Lax, H.; Hirner, C.; Panic, Andrej; Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Niedworok, Christian; Rehme, Christian R.
    The value of an additional scrotal suture during orchidopexy
    In: Journal of Pediatric Urology, Jg. 17, 2021, Nr. 1, S. 82.e1 – 82.e5
    DOI
  • Hadaschik, Boris; Hellmis, Eva
    Therapie des nicht-fernmetastasierten CRPC : Androgenrezeptorinhibition als neuer Therapiestandard beim nicht-fernmetastasierten kastrationsresistenten Prostatakarzinom mit hohem Metastasierungsrisiko
    In: Der Urologe, Jg. 60, 2021, Nr. 6, S. 753 – 759
    DOI (Open Access)
  • Panic, Andrej; Rahmani, N.; Kaspar, Cordelia; Radtke, J.P.; Darr, Christopher; Henkel, Alexander; Hadaschik, Boris; Tschirdewahn, Stephan; Heß, Jochen
    Transrectal Ultrasound Guided Hydrodistension : A New Surgical Way in Transgender Surgery
    In: The Journal of Sexual Medicine, Jg. 18, 2021, Nr. 6, S. 1134 – 1140
    DOI
  • Kaspar, Cordelia; Reis, Henning; Stehling, Florian; Dirksen, Uta; Hadaschik, Boris; Rehme, Christian R.
    Zystisches Nephrom bei einem 15 Monate alten Patienten mit DICER1-Mutation
    In: Der Urologe, Jg. 60, 2021, Nr. 6, S. 776 – 779
    DOI
  • Eisenhardt, Andreas; Schneider, Katharina; Hirche, Herbert; Lax, Hildegard; Hadaschik, Boris; Rehme, Christian R.; Van Gool, Jan D.
    Diagnosis and Empirical Treatment of Urinary Tract Infections in Urologic Outpatients
    In: Urologia Internationalis, Jg. 104, 2020, Nr. 7-8, S. 617 – 624
    DOI
  • Radtke, Jan Philipp; Hadaschik, Boris
    Editorial Comment : [zu Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy]
    In: The Journal of Urology, Jg. 204, 2020, Nr. 3, S. 510
    DOI
  • Püllen, Lukas; Radtke, Jan P.; Wiesenfarth, Manuel; Roobol, Monique J.; Verbeek, Jan F.M.; Wetter, Axel; Guberina, Nika; Pandey, Abhishek; Hüttenbrink, Clemens; Tschirdewahn, Stephan; Pahernik, Sascha; Hadaschik, Boris; Distler, Florian A.
    External validation of novel magnetic resonance imaging-based models for prostate cancer prediction
    In: BJU International (BJUI), Jg. 125, 2020, Nr. 3, S. 407 – 416
    DOI
  • Darr, Christopher; Krafft, Ulrich; Fendler, Wolfgang P.; Costa, P. Fragoso; Barbato, F.; Praus, C.; Reis, Henning; Hager, T.; Tschirdewahn, Stephan; Radtke, J.P.; Herrmann, Ken; Hadaschik, Boris
    First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3194 – 3195
    DOI
  • Darr, Christopher; Harke, Nina; Radtke, Jan Philipp; Yirga, Leubet; Kesch, Claudia; Grootendorst, Maarten; Fendler, Wolfgang P.; Fragoso Costa, Pedro; Rischpler, Christoph; Praus, Christine; Haubold, Johannes; Reis, Henning; Hager, Thomas; Herrmann, Ken; Binse, Ina; Hadaschik, Boris
    Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility study
    In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 10, S. 1500 – 1506
    DOI, Online Volltext (Open Access)
  • Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Calais, Jeremie; Barbato, Francesco; Weber, Manuel; Afshar-Oromieh, Ali; Spohn, Fabian; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang Peter
    Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
    In: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 7, S. 1037 – 1042
    DOI, Online Volltext (Open Access)
  • Chowdhury, Simon; Oudard, Stéphane; Uemura, Hiroji; Joniau, Steven; Pilon, Dominic; Lefebvre, Patrick; McQuarrie, Kelly; Liu, Jinan; Dearden, Lindsay; Sermon, Jan; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris
    Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer
    In: Advances in Therapy, Jg. 37, 2020, Nr. 1, S. 512 – 526
    DOI (Open Access)
  • Chowdhury, Simon; Oudard, Stéphane; Uemura, Hiroji; Joniau, Steven; Pilon, Dominic; Ladouceur, Martin; Behl, Ajay S.; Liu, Jinan; Dearden, Lindsay; Sermon, Jan; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris
    Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
    In: Advances in Therapy, Jg. 37, 2020, S. 501 – 511
    DOI (Open Access)
  • Ohlmann, Carsten H.; Hadaschik, Boris
    Minimalinvasive Chirurgie aggressiver Tumoren
    In: Der Urologe, 2020
    DOI
  • Tschirdewahn, Stephan; Harke, Nina; Hirner, Lucas; Stagge, E.; Hadaschik, Boris; Eisenhardt, Andreas
    Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder : a randomized study in comparison with white light cystoscopy
    In: World Journal of Urology, Jg. 38, 2020, Nr. 6, S. 1509 – 1515
    DOI
  • Krafft, Ulrich; Reis, Henning; Ingenwerth, Marc; Kovalszky, Ilona; Becker, Markus; Niedworok, Christian; Darr, Christopher; Nyirády, Péter; Hadaschik, Boris; Szarvas, Tibor
    Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 1, S. 253 – 261
    DOI
  • Nagy, Nikolett; Reis, Henning; Hadaschik, Boris; Niedworok, Christian; Módos, Orsolya; Szendrői, Attila; Bíró, Krisztina; Hager, Thomas; Herold, Thomas; Ablat, Jason; Black, Peter C.; Okon, Krzysztof; Tolkach, Yuri; Csizmarik, Anita; Oláh, Csilla; Keresztes, David; Bremmer, Felix; Gaisa, Nadine T.; Kriegsmann, Joerg; Kovalszky, Ilona; Kiss, András; Tímár, József; Szász, Marcell A.; Rink, Michael; Fisch, Margit; Nyirády, Péter; Szarvas, Tibor
    Prevalence of APC and PTEN Alterations in Urachal Cancer
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 4, S. 2773 – 2781
    DOI (Open Access)
  • Ferdinandus, Justin; Fendler, Wolfgang Peter; Hadaschik, Boris; Herrmann, Ken
    Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence
    In: Current Opinion in Urology, Jg. 30, 2020, Nr. 5, S. 635 – 640
    DOI
  • Radtke, Jan Philipp; Hadaschik, Boris
    Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
    In: European Urology, Jg. 78, 2020, Nr. 2, S. 291 – 292
    DOI
  • Hadaschik, Boris; Herrmann, Ken
    Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre Study
    In: European Urology, Jg. 78, 2020, Nr. 3, S. 470 – 471
    DOI
  • Darr, Christopher; Krafft, Ulrich; Panic, Andrej; Tschirdewahn, Stephan; Hadaschik, Boris; Rehme, Christian R.
    Renal duplication with ureter duplex not following Meyer-Weigert-Rule with development of a megaureter of the lower ureteral segment due to distal stenosis – A case report
    In: Urology Case Reports, Jg. 28, 2020, 101038
    DOI (Open Access)
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina; Hadaschik, Boris; Nyirády, Péter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Olah, Csilla; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
    In: Pathology & Oncology Research, Jg. 26, 2020, Nr. 2, S. 1243 – 1249
    DOI
  • Niedworok, Christian; Kempkensteffen, Carsten; Eisenhardt, Andreas; Tschirdewahn, Stephan; Rehme, Christian R.; Panic, Andrej; Reis, Henning; Baba, Hideo Andreas; Nyirády, Peter; Hadaschik, Boris; Kovalszky, Ilona; Szarvas, Tibor
    Serum and tissue syndecan-1 levels in renal cell carcinoma
    In: Translational Andrology and Urology, Jg. 9, 2020, Nr. 3, S. 1167 – 1176
    DOI (Open Access)
  • Olah, Csilla; Tschirdewahn, Stephan; Hoffmann, Michèle J.; Krafft, Ulrich; Hadaschik, Boris; Nyirady, Peter; Szendröi, Attila; Módos, Orsolya; Csizmarik, Anita; Kovalszky, Ilona; Reis, Henning; Szarvas, Tibor
    Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patients
    In: Diagnostics, Jg. 10, 2020, Nr. 11, 864
    DOI, Online Volltext (Open Access)
  • Knipper, S.; Graefen, M.; Hadaschik, Boris; Wiegel, T.
    Therapiekonzepte beim primär oligometastasierten Prostatakarzinom
    In: Der Urologe, Jg. 59, 2020, Nr. 6, S. 659 – 664
    DOI
  • Harke, Nina; Radtke, Jan P.; Hadaschik, Boris; Bach, Christian; Berger, Frank P.; Blana, Andreas; Borgmann, Hendrik; Distler, Florian A.; Edeling, Sebastian; Egner, Tobias; Engels, Christina L.; Farzat, Mahmoud; Haese, Alexander; Hein, Rainer; Kuczyk, Markus A.; Manseck, Andreas; Moritz, Rudolf; Musch, Michael; Peters, Inga; Pokupic, Sasa; Rocco, Bernardo; Schneider, Andreas; Schumann, André; Schwentner, Christian; Sighinolfi, Chiara M.; Buse, Stephan; Stolzenburg, Jens-Uwe; Truß, Michael C.; Waldner, Michael; Wülfing, Christian; Zimmermanns, Volker; Witt, Jörn H.; Wagner, Christian
    To defer or not to defer? : A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic
    In: PLoS ONE, Jg. 15, 2020, Nr. 9, S. e0239027
    DOI (Open Access)
  • Hager, Thomas; Kraywinkel, Klaus; Szarvas, Tibor; Hadaschik, Boris; Schmid, Kurt Werner; Reis, Henning
    Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison study
    In: Urologia Internationalis, Jg. 104, 2020, Nr. 9-10, S. 803 – 809
    DOI
  • Kasper, Stefan; Virchow, Isabel; Hadaschik, Boris; Radtke, Jan Philipp
    Was erwartet der Nichtradiologe vom Radiologen?
    In: Der Radiologe, Jg. 60, 2020, Nr. 5, S. 421 – 429
    DOI
  • Guberina, Nika; Hetkamp, Philipp; Rübben, Herbert; Fendler, Wolfgang; Grueneisen, J.; Suntharalingam, S.; Kirchner, J.; Püllen, Lukas; Harke, Nina; Radtke, J.P.; Umutlu, Lale; Hadaschik, Boris; Herrmann, Ken; Forsting, Michael; Wetter, Axel
    Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of Reference
    In: Molecular Imaging and Biology, Jg. 22, 2020, Nr. 3, S. 788 – 796
    DOI
  • Grummet, Jeremy; Gorin, Michael A.; Popert, Rick; O’Brien, Tim; Lamb, Alastair D.; Hadaschik, Boris; Radtke, Jan Philipp; Wagenlehner, Florian; Baco, Eduard; Moore, Caroline M.; Emberton, Mark; George, Arvin K.; Davis, John W.; Szabo, Richard J.; Buckley, Roger; Loblaw, Andrew; Allaway, Matthew; Kastner, Christof; Briers, Erik; Royce, Peter L.; Frydenberg, Mark; Murphy, Declan G.; Woo, Henry H.
    “TREXIT 2020” : Why the time to abandon transrectal prostate biopsy starts now
    In: Prostate Cancer and Prostatic Diseases, Jg. 23, 2020, Nr. 1, S. 62 – 65
    DOI (Open Access)
  • De Visschere, Pieter J.L.; Standaert, Chloë; Fütterer, Jurgen J.; Villeirs, Geert M.; Panebianco, Valeria; Walz, Jochen; Maurer, Tobias; Hadaschik, Boris; Lecouvet, Frédéric E.; Giannarini, Gianluca; Fanti, Stefano
    A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
    In: European Urology Oncology, Jg. 2, 2019, Nr. 1, S. 47 – 76
    DOI (Open Access)
  • Leyh-Bannurah, Sami-Ramzi; Cash, Hannes; Borkowetz, Angelika; Graefen, Markus; Schlomm, Thorsten; Hadaschik, Boris; Budäus, Lars
    Active Surveillance und die moderne Diagnostik des Prostatatkarzinoms : Multiparametrische MRT, Fusionsbiopsien und neue genetische Biomarker
    In: Der Onkologe, Jg. 25, 2019, Nr. 4, S. 304 – 314
    DOI
  • Small, Eric J.; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie; Olmos, David; Mainwaring, Paul; Lee, J.Y.; Uemura, Hiroshi; De Porre, Peter; Smith, Ariane; Zhang, Ke; Lopez-Gitlitz, Angela; Smith, Matthew R.
    Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
    In: Annals of Oncology, Jg. 30, 2019, Nr. 11, S. 1813 – 1820
    DOI (Open Access)
  • Tschirdewahn, Stephan; Panic, Andrej; Püllen, Lukas; Harke, Nina; Hadaschik, Boris; Riesz, Peter; Horváth, Andras; Szalontai, Janos; Nyirády, Peter; Baba, Hideo Andreas; Reis, Henning; Szarvas, Tibor
    Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma
    In: International Journal of Cancer, Jg. 145, 2019, Nr. 2, S. 531 – 539
    DOI
  • Reis, Henning; Mairinger, F.; Ting, Saskia; Nagy, N.; Witzke, K.E.; Kohl, M.; Sitek, B.; Niedworok, Christian; Hadaschik, Boris; Nyirády, P.; Szarvas, Tibor
    Das Urachuskarzinom : Ein Update aktueller molekularer Ergebnisse
    In: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 239 – 243
    DOI
  • Püllen, Lukas; Hadaschik, Boris; Eberli, D.; Kuru, T. H.
    Die Fusionsbiopsie in der Primärdiagnostik des Prostatakarzinoms : Durchführung, Nutzen und klinische Aspekte
    In: Der Urologe, Jg. 58, 2019, Nr. 5, S. 504 – 510
    DOI
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Londhe, Anil; Bhaumik, Amitabha; Cheng, Shinta; Rooney, Oliver Brendan; Smith, Matthew Raymond
    Efficacy of apalutamide (APA) plus ongoing androgen deprivation therapy (ADT) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) and baseline (BL) comorbidities (CM)
    In: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 15_Suppl, S. 5023 – 5023
    DOI
  • Kesch, Claudia; Hadaschik, Boris
    Ein neuer Androgenrezeptorantagonist : Darolutamid für Patienten mit nicht fernmetastasiertem, kastrationsresistentem Prostatakarzinom
    In: Der Urologe, Jg. 58, 2019, Nr. 10, S. 1217 – 1218
    DOI
  • Hallanzy, Jacqueline; Kron, Martina; Goethe, Veronika E.; Köhn, Frank-Michael; Schmautz, Maximilian; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen E.; Herkommer, Kathleen
    Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities : Results From the German Male Sex Study
    In: Sexual Medicine, Jg. 7, 2019, Nr. 1, S. 26 – 34
    DOI (Open Access)
  • Meissner, Valentin H.; Schroeter, Lukas; Köhn, Frank-Michael; Kron, Martina; Zitzmann, Michael; Arsov, Christian; Imkamp, Florian; Hadaschik, Boris; Gschwend, Jürgen E.; Herkommer, Kathleen
    Factors Associated with Low Sexual Desire in 45-Year-Old Men : Findings from the German Male Sex-Study
    In: The Journal of Sexual Medicine, Jg. 16, 2019, Nr. 7, S. 981 – 991
    DOI
  • Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Eiber, Matthias; Afshar-Oromieh, Ali; Spohn, Fabian; Barbato, Francesco; Weber, Manuel; Ilhan, Harun; Cervati, Veronica; Wetter, Axel; Hadaschik, Boris; Briganti, Alberto; Walz, Jochen; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken; Fendler, Wolfgang Peter
    Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study
    In: The Journal of Urology, Jg. 202, 2019, Nr. 6, S. 1174 – 1181
    DOI
  • Szarvas, Tibor; Jardin-Watelet, Bénédicte; Bourgoin, Nicolas; Hoffmann, Michèle J; Nyirady, Peter; Oláh, Csilla; Széll, Tamás; Csizmarik, Anita; Hadaschik, Boris; Reis, Henning
    High soluble CGA levels are associated with poor survival in bladder cancer
    In: Endocrine Connections, Jg. 8, 2019, Nr. 5, S. 625 – 633
    DOI, Online Volltext (Open Access)
  • Feng, Felix Y; Thomas, Shibu; Gormley, Michael; Lopez-Gitlitz, Angela; Yu, Margaret K.; Cheng, Shinta; Ricci, Deborah S.; Rooney, Oliver Brendan; Mainwaring, Paul N.; Olmos, David; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris; Fishbane, Nicholas; Davicioni, Elai; Liu, Yang; Small, Eric Jay; Smith, Matthew Raymond
    Identifying molecular determinants of response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the SPARTAN trial.
    In: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 7_Suppl, S. 42 – 42
    DOI
  • Pomykala, Kelsey L.; Farolfi, Andrea; Hadaschik, Boris; Fendler, Wolfgang P.; Herrmann, Ken
    Molecular Imaging for Primary Staging of Prostate Cancer
    In: Seminars in Nuclear Medicine, Jg. 49, 2019, Nr. 4, S. 271 – 279
    DOI
  • Taplin, Mary-Ellen; Gleave, Martin; Evans, Christopher P.; Efstathiou, Eleni; Kantoff, Philip W.; Ross, Ashley; Shore, Neal D.; Briganti, Alberto; Hadaschik, Boris; Heidenreich, Axel; Rooney, Oliver Brendan; Tian, Shaozhou Ken; Wetherhold, Lisa; Xu, Weichun; Cheng, Shinta; Kibel, Adam S.
    PROTEUS : A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)
    In: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 15_Suppl, S. TPS5100 – TPS5100
    DOI
  • Maurer, Tobias; Hadaschik, Boris; Budäus, Lars Henrik; Steuber, Thomas; Salomon, Georg; Horn, Thomas; Herrmann, Ken; Weber, Manuel; Giesel, Frederik Lars; Berliner, C.; Eiber, Matthias J.
    PSA-Anstieg nach definitiver Therapie
    In: Der Urologe, Jg. 58, 2019, Nr. 5, S. 569 – 582
    DOI
  • Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris
    Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer
    In: Clinical Cancer Research, Jg. 25, 2019, Nr. 24, S. 7448 – 7454
    DOI (Open Access)
  • Breidenstein, Anja; Heß, Jochen A.; Hadaschik, Boris; Teufel, Martin; Tagay, Sefik
    Psychosocial Resources and Quality of Life in Transgender Women following Gender-Affirming Surgery
    In: The Journal of Sexual Medicine, Jg. 16, 2019, Nr. 10, S. 1672 – 1680
    DOI
  • Hallanzy, Jacqueline; Kron, Martina; Goethe, Veronika E.; Köhn, Frank Michael; Schmautz, Maximilian; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen Erich; Herkommer, Kathleen
    Re: Erectile dysfunction in 45-year-old heterosexual German men and associated lifestyle risk factors and comorbidities : Results from the German Male sex study
    In: The Journal of Urology, Jg. 202, 2019, Nr. 4, S. 644
    DOI
  • Ohlmann, Carsten-Henning; Hadaschik, Boris
    Re: Minimally Invasive Versus Abdominal Radical Hysterectomy for Cervical Cancer
    In: European Urology, Jg. 75, 2019, Nr. 5, S. 875
    DOI
  • Grünwald, Viktor; Hadaschik, Boris
    Re: Preliminary Results for Avelumab Plus Axitinib as First-Line Therapy in Patients with Advanced Clear-cell Renal-cell Carcinoma (JAVELIN Renal 100) : An Open-label, Dose-finding and Dose-expansion, Phase 1b Trial
    In: European Urology, Jg. 75, 2019, Nr. 4, S. 697 – 698
    DOI
  • Barbato, Francesco; Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Weber, Manuel; Wetter, Axel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang Peter; et al.
    Reply by Authors
    In: The Journal of Urology, Jg. 202, 2019, Nr. 6, S. 1181
    DOI
  • Darr, Christopher; Hadaschik, Boris A.; Tschirdewahn, Stephan
    Systemtherapie des metastasierten Tumors des oberen Harntraktes
    In: Der Urologe, Jg. 58, 2019, Nr. 1, S. 30 – 33
    DOI
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Espina, Byron M.; Shu, Youyi; Rackoff, Wayne R.; Rooney, Oliver Brendan; Londhe, Anil; Cheng, Shinta; Smith, Matthew Raymond
    Updated analysis of progression-free survival with first subsequent therapy (PFS2) and safety in the SPARTAN study of apalutamide (APA) in patients (pts) with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC).
    In: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 7_Suppl, S. 144 – 144
    DOI
  • Krafft, Ulrich; Tschirdewahn, Stephan; Heß, Jochen A.; Harke, Nina N.; Hadaschik, Boris; Olah, Csilla; Krege, Susanne; Nyirády, Peter; Szendröi, Attila; Szücs, Miklós; Módos, Orsolya; Székely, Eszter; Reis, Henning; Szarvas, Tibor
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 37, 2019, Nr. 11, S. 810.e7 – 810.e15
    DOI
  • Sachpekidis, Christos; Pan, Leyun; Hadaschik, Boris; Kopka, Klaus; Haberkorn, Uwe; Dimitrakopoulou-Strauss, Antonia
    68Ga-PSMA-11 PET/CT in prostate cancer local recurrence : impact of early images and parametric analysis
    In: American Journal of Nuclear Medicine and Molecular Imaging, Jg. 8, 2018, Nr. 5, S. 351 – 359
    (Open Access)
  • Smith, Matthew R.; Saad, Fred; Chowdhury, Simon; Oudard, Stéphane; Hadaschik, Boris; Graff, Julie N.; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Lopez-Gitlitz, Angela; Trudel, Géralyn C.; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.; Small, Eric J.
    Apalutamide treatment and metastasis-free survival in prostate cancer
    In: The New England Journal of Medicine, Jg. 378, 2018, Nr. 15, S. 1408 – 1418
    DOI, Online Volltext (Open Access)
  • Harke, Nina; Mandel, Philipp; Witt, Jorn H.; Wagner, Christian; Panic, Andrej; Boy, Anselm; Roosen, Alexander; Ubrig, Burkhard; Schneller, Andreas; Schiefelbein, Frank; Wagener, Nina; Honeck, Patrick; Schoen, Georg; Hadaschik, Boris; Michel, Maurice S.; Kriegmair, Maximilian C.
    Are there limits of robotic partial nephrectomy? : TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumors
    In: Journal of Surgical Oncology, Jg. 118, 2018, Nr. 1, S. 206 – 211
    DOI
  • Reis, Henning; Krafft, Ulrich; Niedworok, Christian; Módos, Orsolya; Herold, Thomas; Behrendt, Mark; Al-Ahmadie, Hikmat; Hadaschik, Boris; Nyirady, Peter; Szarvas, Tibor
    Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own Data
    In: Disease Markers, 2018, 7308168
    DOI (Open Access)
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, Henning; Hadaschik, Boris; Shariat, Shahrokh F.; Kramer, Gero
    Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer
    In: Urologic Oncology: Seminars and Original Investigations, Jg. 36, 2018, Nr. 6, S. 312.e9 – 312.e15
    DOI, Online Volltext (Open Access)
  • Lang, Stephan; Bruderek, Kirsten; Kaspar, Cordelia; Höing, Benedikt; Kanaan, Oliver; Dominas, Nina; Hussain, Timon; Droege, Freya; Eyth, Christian; Hadaschik, Boris; Brandau, Sven
    Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
    In: Clinical Cancer Research, Jg. 24, 2018, Nr. 19, S. 4834 – 4844
    DOI (Open Access)
  • Goethe, Veronika E.; Angerer, Hannes; Dinkel, Andreas; Arsov, Christian; Hadaschik, Boris; Imkamp, Florian; Gschwend, Jürgen E.; Herkommer, Kathleen
    Concordance and Discordance of Sexual Identity, Sexual Experience, and Current Sexual Behavior in 45-Year-Old Men : Results From the German Male Sex-Study
    In: Sexual Medicine, Jg. 6, 2018, Nr. 4, S. 282 – 290
    DOI (Open Access)
  • Kesch, Claudia; Radtke, Jan-Philipp; Wintsche, Axel; Wiesenfarth, Manuel; Luttje, Mariska; Gasch, Claudia; Dieffenbacher, Svenja; Pecqueux, Carine; Teber, Dogu; Hatiboglu, Gencay; Nyarangi-Dix, Joanne; Simpfendörfer, Tobias; Schönberg, Gita; Dimitrakopoulou-Strauss, Antonia; Freitag, Martin; Duensing, Anette; Grüllich, Carsten; Jäger, Dirk; Götz, Michael; Grabe, Niels; Schweiger, Michal-Ruth; Pahernik, Sascha; Perner, Sven; Herpel, Esther; Roth, Wilfried; Wieczorek, Kathrin; Maier-Hein, Klaus; Debus, Jürgen; Haberkorn, Uwe; Giesel, Frederik; Galle, Jörg; Hadaschik, Boris; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Bonekamp, David; Sültmann, Holger; Duensing, Stefan
    Correlation between genomic index lesions and mpMRI and ⁶⁸Ga-PSMA-PET/CT imaging features in primary prostate cancer
    In: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 16708
    DOI (Open Access)
  • Boegemann, Martin; Arsov, Christian; Hadaschik, Boris; Herkommer, Kathleen; Imkamp, Florian; Nofer, Jerzy-Roch; Gerß, Joachim; Albers, Peter; Semjonow, Axel
    Discordant prostate specific antigen test results despite WHO assay standardization
    In: The International Journal of Biological Markers (IJBM), Jg. 33, 2018, Nr. 3, S. 275 – 282
    DOI (Open Access)
  • Saad, Fred; Cella, David; Basch, Ethan; Hadaschik, Boris; Mainwaring, Paul N.; Oudard, Stéphane; Graff, Julie N.; McQuarrie, Kelly; Li, Susan; Hudgens, Stacie; Lawson, Joe; Lopez-Gitlitz, Angela; Yu, Margaret K.; Smith, Matthew R.; Small, Eric J.
    Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
    In: The Lancet Oncology, Jg. 19, 2018, Nr. 10, S. 1404 – 1416
    DOI (Open Access)
  • Harke, Nina Natascha; Godes, Michael; Wagner, Christian; Addali, Mustapha; Fangmeyer, Bernhard; Urbanova, Katarina; Hadaschik, Boris; Witt, Jorn H.
    Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy : a prospective, randomized trial
    In: World Journal of Urology, Jg. 36, 2018, Nr. 11, S. 1817 – 1823
    DOI
  • Warsow, Gregor; Hübschmann, Daniel; Kleinheinz, Kortine; Nientiedt, Cathleen; Heller, Martina; Van Coile, Laura; Tolstov, Yanis; Trennheuser, Lukas; Wieczorek, Kathrin; Pecqueux, Carine; Gasch, Claudia; Kuru, Timur; Nyarangi-Dix, Joanne; Hatiboglu, Gencay; Teber, Dogu; Perner, Sven; Stenzinger, Albrecht; Roth, Wilfried; Hadaschik, Boris; Pahernik, Sascha; Jäger, Dirk; Grüllich, Carsten; Duensing, Anette; Eils, Roland; Schlesner, Matthias; Sültmann, Holger; Hohenfellner, Markus; Duensing, Stefan
    Genomic features of renal cell carcinoma with venous tumor thrombus
    In: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 7477
    DOI (Open Access)
  • Afshar-Oromieh, Ali; Debus, Nils; Uhrig, Monika; Hope, Thomas A.; Evans, Michael J.; Holland-Letz, Tim; Giesel, Frederik L.; Kopka, Klaus; Hadaschik, Boris; Kratochwil, Clemens; Haberkorn, Uwe
    Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 12, S. 2045 – 2054
    DOI (Open Access)
  • Kasivisvanathan, Veeru; Rannikko, Antti S.Sakari; Borghi, Marcelo; Panebianco, Valeria; Mynderse, Lance A.; Vaarala, Markku H.; Briganti, Alberto; Budäus, Lars Henrik; Hellawell, Giles O.; Hindley, Richard Graham; Roobol, Monique J.; Eggener, Scott E.; Ghei, Maneesh; Villers, Arnauld A.; Bladou, Franck; Villeirs, Geert M.; Virdi, Jaspal S.; Boxler, Silvan; Robert, Grégoire Y.; Singh, Paras B.; Venderink, Wulphert; Hadaschik, Boris; Ruffion, Alain; Hu, Jim C.; Margolis, Daniel Jason Aaron; Crouzet, Sébastien; Klotz, Laurence H.; Taneja, Samir S.; Pinto, Peter A.; Gill, Inderbir S.; Allen, Clare M.; Giganti, Francesco; Freeman, Alex A.; Morris, Stephen J.; Punwani, Shonit; Williams, Norman R.; Brew-Graves, Chris; Deeks, Jonathan J.; Takwoingi, Yemisi; Émberton, Mark E.; Moore, Caroline M.; F.R.C.S.(Urol.) for the PRECISION Study Group Collaborators
    MRI-targeted or standard biopsy for prostate-cancer diagnosis
    In: The New England Journal of Medicine, Jg. 378, 2018, Nr. 19, S. 1767 – 1777
    DOI (Open Access)
  • Chowdhury, S.; Oudard, S.; Hadaschik, Boris; Uemura, H.; Joniau, S.; Pilon, D.; Ladouceur, M.; Behl, A.; Liu, J.; Dearden, L.; Sermon, J.; Van Sanden, S.; Diels, J.
    Matching-adjusted indirect comparison of the effiacy of apalutamide and enzalutamide in the treatment of non-metastatic castration-resistant prostate cancer
    In: Value in Health, Jg. 21, 2018, Nr. Suppl. 3, S. 20 – S21
    DOI (Open Access)
  • Szarvas, Tibor; Sevcenco, Sabina; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Csizmarik, Anita; Ristl, Robin; Puhr, Martin; Hoffmann, Michèle J.; Niedworok, Christian; Hadaschik, Boris; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero
    Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer
    In: BJU International (BJUI), Jg. 122, 2018, Nr. 4, S. 695 – 704
    DOI, Online Volltext (Open Access)
  • Hansen, Nienke L.; Barrett, Tristan; Kesch, Claudia; Pepdjonovic, Lana; Bonekamp, David; O'Sullivan, Richard; Distler, Florian; Warren, Anne; Samel, Christina; Hadaschik, Boris; Grummet, Jeremy; Kastner, Christof
    Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer
    In: BJU International (BJUI), Jg. 122, 2018, Nr. 1, S. 40 – 49
    DOI (Open Access)
  • Kesch, Claudia; Schütz, Viktoria; Dieffenbacher, Svenja; Bonekamp, David; Hadaschik, Boris; Hohenfellner, Markus; Radtke, Jan P.
    Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer
    In: Current Opinion in Urology, Jg. 28, 2018, Nr. 2, S. 172 – 177
    DOI
  • Hadaschik, Boris; Panic, Andrej
    Neue Therapieoption : Apalutamid beim nicht fernmetastasierten kastrationsresistenten Prostatakarzinom
    In: Der Urologe, Jg. 57, 2018, Nr. 6, S. 729 – 730
    DOI
  • Baranski, Ann-Christin; Schäfer, Martin; Bauder-Wüst, Ulrike; Roscher, Mareike; Schmidt, Jana; Stenau, Esther; Simpfendörfer, Tobias; Teber, Dogu; Maier-Hein, Lena; Hadaschik, Boris; Haberkorn, Uwe; Eder, Matthias; Kopka, Klaus
    PSMA-11–Derived dual-Labeled PSMA inhibitors for preoperative PET imaging and precise fluorescence-Guided surgery of prostate cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 4, S. 639 – 645
    DOI (Open Access)
  • Hadaschik, Boris
    Paradigmenwechsel in der Urologie : Prostatakrebsdiagnostik mittels MRT-gezielter oder konventioneller transrektaler ultraschallgesteuerter Biopsie
    In: Der Urologe, Jg. 57, 2018, Nr. 6, S. 727 – 728
    DOI
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer, Jg. 143, 2018, Nr. 7, S. 1764 – 1773
    DOI, Online Volltext (Open Access)
  • Ganzer, Roman; Hadaschik, Boris; Pahernik, Sascha; Koch, Daniel; Baumunk, Daniel; Kuru, Timur; Heidenreich, Axel; Stolzenburg, Jens-Uwe; Schostak, Martin; Blana, Andreas
    Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound
    In: The Journal of Urology, Jg. 199, 2018, Nr. 4, S. 983 – 989
    DOI
  • Borkowetz, Angelika; Hadaschik, Boris; Platzek, Ivan; Toma, Marieta; Torsev, Georgi; Renner, Theresa; Herout, Roman; Baunacke, Martin; Laniado, Michael; Baretton, Gustavo; Radtke, Jan Philipp; Kesch, Claudia; Hohenfellner, Markus; Froehner, Michael; Schlemmer, Heinz-Peter; Wirth, Manfred; Zastrow, Stefan
    Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients
    In: BJOG: formerly: The Journal of Obstetrics and Gynaecology of the British Commonwealth / of the British Empire; British Journal of Obstetrics and Gynaecology, Jg. 121, 2018, Nr. 1, S. 53 – 60
    DOI (Open Access)
  • Eiber, Matthias; Herrmann, Ken; Calais, Jeremie; Hadaschik, Boris; Giesel, Frederik L.; Hartenbach, Markus; Hope, Thomas; Reiter, Robert; Maurer, Tobias; Weber, Wolfgang A.; Fendler, Wolfgang P.
    Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CT
    In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 3, S. 469 – 478
    DOI (Open Access)
  • Heß, Jochen A.; Henkel, Alexander; Bohr, Julia; Rehme, Christian R.; Panic, Andrej; Panic, Leo; Rossi Neto, R.; Hadaschik, Boris; Heß, Yasmine
    Sexuality after Male-to-Female Gender Affirmation Surgery
    In: BioMed Research International, 2018, 9037979
    DOI, Online Volltext (Open Access)
  • Darr, Christopher; Krafft, Ulrich; Hadaschik, Boris; Tschirdewahn, Stephan; Sevcenco, Sabina; Csizmarik, Anita; Nyirady, Peter; Küronya, Zsófia; Reis, Henning; Maj-Hes, Agnieszka; Shariat, Shahrokh F.; Kramer, Gero; Szarvas, Tibor
    The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
    In: Urologia Internationalis, Jg. 101, 2018, Nr. 1, S. 65 – 73
    DOI
  • Sachpekidis, Christos; Bäumer, P.; Kopka, K.; Hadaschik, Boris; Hohenfellner, M.; Kopp-Schneider, A.; Haberkorn, U.; Dimitrakopoulou-Strauss, A.
    ⁶⁸Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 45, 2018, Nr. 6, S. 904 – 912
    DOI
  • Vinsensia, Maria; Chyoke, Peter L.; Hadaschik, Boris; Holland-Letz, Tim; Moltz, Jan Hendrik; Kopka, Klaus; Rauscher, Isabel; Mier, Walter; Schwaiger, Markus C.; Haberkorn, Uwe; Mauer, Tobias; Kratochwil, Clemens; Eiber, Matthias J.; Giesel, Frederik Lars
    68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 12, S. 1949 – 1955
    DOI
  • Radtke, Jan Philipp; Wiesenfarth, Manuel; Kesch, Claudia; Freitag, Martin T.; Alt, Celine D.; Celik, Kamil; Distler, Florian; Roth, Wilfried; Wieczorek, Kathrin; Stock, Christian; Duensing, Stefan; Roethke, Matthias C.; Teber, Dogu; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Bonekamp, David; Hadaschik, Boris
    Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer : Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies
    In: European Urology, Jg. 72, 2017, Nr. 6, S. 888 – 896
    DOI
  • Roth, Wilfried; Duensing, Stefan; Macher-Goeppinger, Stephan; Falkenstein, Michael; Walter, Britta; Schecher, Sabrina; Tagscherer, Katrin E.; Hadaschik, Boris; Stenzel, Philipp; Perner, Sven; Kristiansen, Glen; Krümpelmann, Kristina
    Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer
    In: International Journal of Cancer, Jg. 141, 2017, Nr. 8, S. 1643 – 1653
    DOI
  • Ganzer, R.; Franiel, T.; Köllermann, J.; Kuru, T.; Baumunk, D.; Blana, A.; Hadaschik, Boris; von Hardenberg, J.; Henkel, T.; Köhrmann, K.-U.; Liehr, U.-B.; Machtens, S.; Roosen, A.; Salomon, G.; Schlemmer, H.-P.; Sentker, L.; Wendler, J.; Witzsch, U.; Schostak, M.
    Fokale Therapie des Prostatakarzinoms
    In: Der Urologe, Jg. 56, 2017, Nr. 10, S. 1335 – 1346
    DOI
  • Schäfer, Martin; Giesel, Frederik L.; Hadaschik, Boris; Ellert, Elena; Kopka, Klaus; Schlemmer, Heinz P.; Radtke, Jan P.; Kesch, Claudia; Vinsensia, Maria; Heller, Martina; Neels, Oliver C.; Cardinale, Jens; Grabe, Nils; Afshar-Oromieh, Ali; Kratochwil, Clemens; Holland-Letz, Tim; Duensing, Stefan; Hohenfellner, Markus; Haberkorn, Uwe; Wieczorek, Kathrin
    Intraindividual Comparison of18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer : A Retrospective, Proof-of-Concept Study
    In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, S. 1805 – 1810
    DOI
  • Heußer, Thorsten; Mann, Philipp; Rank, Christopher M.; Schäfer, Martin; Dimitrakopoulou-Strauss, Antonia; Schlemmer, Heinz-Peter; Hadaschik, Boris; Kopka, Klaus; Bachert, Peter; Kachelrieß, Marc; Freitag, Martin T.
    Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI
    In: PLoS ONE, Jg. 12, 2017, Nr. 8, S. e0183329
    DOI (Open Access)
  • Bergero, Miguel A.; Martínez, Pablo F.; Radtke, Jan P.; Hadaschik, Boris
    Multiparametric-MRI-guided biopsy in the era of precision medicine
    In: Archivos Espanoles de Urologia, Jg. 70, 2017, Nr. 10, S. 833 – 844
  • Nyarangi-Dix, Joanne N.; Steimer, J.; Bruckner, Thomas M.; Jakobi, Hildegard; Koerber, Stefan A.; Hadaschik, Boris; Debus, Debus, Jürgen P.; Hohenfellner, Markus R.
    Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime
    In: World Journal of Urology, Jg. 35, 2017, Nr. 12, S. 1841 – 1847
    DOI
  • Hadaschik, Boris; Herrmann, Ken
    Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
    In: European Urology, Jg. 72, 2017, Nr. 3, S. 470 – 471
    DOI
  • Distler, Florian A.; Radtke, Jan P.; Bonekamp, David; Kesch, Claudia; Schlemmer, Heinz-Peter; Wieczorek, Kathrin; Kirchner, Marietta; Pahernik, Sascha; Hohenfellner, Markus; Hadaschik, Boris
    The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction
    In: The Journal of Urology, Jg. 198, 2017, Nr. 3, S. 575 – 582
    DOI
  • Ceci, Francesco; Herrmann, Ken; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano
    Therapy assessment in prostate cancer using choline and PSMA PET/CT
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 44, 2017, Nr. Suppl. 1, S. S78 – S83
    DOI
  • Grummet, Jeremy; Pepdjonovic, Lana; Huang, Sean; Anderson, Elliot; Hadaschik, Boris
    Transperineal vs. transrectal biopsy in MRI targeting
    In: Translational Andrology and Urology, Jg. 6, 2017, Nr. 3, S. 368 – 375
    DOI (Open Access)

    • Aufsätze

  • Hadaschik, Boris; Ost, Piet
    Re: Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical Trial
    In: European Urology. Amsterdam: Elsevier, Jg. 76, 2019, Nr. 4, S. 538 – 539
    DOI

    • Vorworte / Nachworte

  • Thomas, Christian; Hadaschik, Boris
    Neues zum metastasierten Prostatakarzinom : Wer die Wahl hat, hat die Qual
    In: Die Urologie. Berlin: Springer, Jg. 64, 2025, Nr. 3, S. 217 – 219
    DOI (Open Access)
  • Fendler, Wolfgang; Grünwald, Viktor; Herrmann, Ken; Hadaschik, Boris
    Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker : Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate Cancer
    In: European Urology. Amsterdam: Elsevier, Jg. 87, 2025, Nr. 3, S. 275 – 277
    DOI
  • Krafft, Ulrich; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken
    A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
    In: European Urology. Amsterdam: Elsevier, Jg. 85, 2024, Nr. 3, S. 227 – 228
    DOI
  • Seifert, Robert; Eiber, Matthias; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang
    The novel PROMISE framework for PSMA-PET reporting : Ready for the clinical routine?
    In: Clinical and Translational Imaging. Berlin: Springer, Jg. 12, 2024, Nr. 1, S. 1 – 3
    DOI (Open Access)
  • Hadaschik, Boris; Merseburger, Axel
    Das metastasierte kastrationsresistente Prostatakarzinom : praxisrelevante Hilfestellungen für individuelle Therapieentscheidungen
    In: Die Urologie. Berlin: Springer, Jg. 62, 2023, Nr. 12, S. 1267 – 1268
    DOI
  • Hadaschik, Boris; Stief, Christian
    Aktuelle Bildgebung für Urologen : Moderne Diagnostik in Praxis und Klinik
    In: Der Urologe. Berlin: Springer Medizin, Jg. 61, 2022, Nr. 4, S. 355 – 356
    DOI (Open Access)
  • Thomas, Christian; Hadaschik, Boris
    Oligometastasierte und lokal fortgeschrittene urologische Tumoren : Moderne Diagnostik vor individualisierter multimodaler Therapie
    In: Der Urologe. Berlin: Springer Medizin, Jg. 60, 2021, Nr. 12, S. 1525 – 1526
    DOI (Open Access)
  • Fazekas, Tamás; Szarvas, Tibor; Csizmarik, Anita; Hadaschik, Boris; Nyirády, Péter
    COVID-19 research : promising tracks leading to uro-oncology
    In: International Urology and Nephrology. Berlin: Springer, Jg. 52, 2020, Nr. 6, S. 995 – 997
    DOI (Open Access)
  • Vaz, Sofia; Hadaschik, Boris; Gabriel, Michael; Herrmann, Ken; Eiber, Matthias; Costa, Durval
    Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. 1, S. 9 – 15
    DOI (Open Access)
  • Fanti, Stefano; Hadaschik, Boris; Herrmann, Ken
    Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression Criteria
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. 5, S. 678 – 682
    DOI (Open Access)
  • Hadaschik, Boris; Merseburger, A.S.
    Therapie des oligo- und polytopmetastasierten Prostatakarzinoms
    In: Der Urologe. Berlin: Springer Medizin, Jg. 59, 2020, Nr. 6, S. 657 – 658
    DOI (Open Access)
  • Hadaschik, Boris; Stief, C.G.
    Management des lokal begrenzten Prostatakarzinoms
    In: Der Urologe. Berlin: Springer Medizin, Jg. 58, 2019, Nr. 5, S. 485
    DOI (Open Access)
  • Hadaschik, Boris; Boegemann, Martin
    Why targeting of PSMA is a valuable adDition to the management of castration-resistant prostate cancer : The urologist's point of view
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 58, 2017, Nr. 8, S. 1207 – 1209
    DOI

    • Abstracts

  • Pabst, Kim; Bartel, Timo; Sandach, Patrick; Weber, Manuel; Laschinsky, Christina; Eckstein, Markus; Kessler, Lukas; Kueper, Alina; Hadaschik, Boris; Kesch, Claudia; Hamacher, Rainer; Nader, Michael; Siveke, Jens; von Tresckow, Bastian; Kümmel, Sherko; Podleska, Lars; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang
    68Ga-FAPI-46 PET for Imaging of FAP-expressing Cancer : Results from a Prospective, Single-Arm, Interventional Phase 2 Clinical Trial
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251524
    Online Volltext (Open Access)
  • Hüsing, Anika; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang; Rahbar, Kambiz
    Three-tier risk stratification of prostate cancer by PSMA-PET PROMISE (PPP2) : Results from an international multi-centre registry study
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251292
    Online Volltext (Open Access)
  • Placke, Jan-Malte; Zimmer, Lisa; Livingstone, Elisabeth; Rösch, Alexander; Lodde, Georg; Tasdogan, Alpaslan; Becker, Jürgen; Griewank, Klaus; Hadaschik, Boris; Schadendorf, Dirk; Ugurel, Selma
    PD-L1 Expression in Lymph Node Metastases as a Predictor of adjuvant Immunotherapy Success in Stage III Melanoma Patients: An Analysis of the prospective ADOREG Study TRIM-ADJUVANT
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 22, 2024, Nr. Suppl. 4, S. 15 – 16
    DOI
  • Fendler, Wolfgang; Karpinski, M.; Hüsing, J.; Claassen, K.; Kajüter, H.; Oesterling, F.; Grünwald, Viktor; Umutlu, Lale; Telli, T.; Merkel-Jens, A.; Huesing, A.; Kesch, C.; Hoberück, S.; Meyer, P.; Kind, F.; Rahbar, K.; Schäfers, M.; Stang, Andreas; Herrmann, Ken; Hadaschik, Boris
    PSMA-PET and PROMISE re-define stage and risk in patients with prostate cancer
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S971
    DOI
  • Fendler, Wolfgang; Karpinski, Madeleine J.; Hüsing, Johannes; Claassen, Kevin; Möller, Lennart; Kajüter, Hiltraud; Oesterling, Florian; Grünwald, Viktor; Umutlu, Lale; Lanzafame, Helena; Telli, Tugce; Merkel-Jens, Anja; Hüsing, Anika; Kesch, Claudia; Herrmann, Ken; Stang, Andreas; Hadaschik, Boris A.
    Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 5016
    DOI
  • Grünwald, Viktor; Thomas, Christian; De Santis, Maria; Gratzke, Christian; Chun, Felix; Mager, Rene; Retz, Margitta; Von Amsberg, Gunhild; Ivanyi, Philipp; Christian, Bolenz; Kübler, Hubert; Hadaschik, Boris; Hahn, Svenja; Erhard, Ian; Reiter, Bastian; Lablans, Martin; Vehreschild, Janne; Brucker, Daniel; Maier, Daniel
    Real-world outcomes of patients with operable renal cell carcinoma from the German translational cancer research consortium (DKTK) network
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 4, S. 394
    DOI (Open Access)
  • Darr, Christopher; Klümper, Niklas; Büttner, Thomas; Holzwarth, Nina; Biernath, Nadine; Höllein, Alexander; Niegisch, Guenter; Seidl, Daniel; Handke, Analena; Paffenholz, Pia; Schlack, Katrin; Cathomas, Richard; Erne, Eva; Banek, Severine; Tauber, Robert; Casuscelli, Jozefina; Seitz, Anna Katharina; Hadaschik, Boris A.; Grünwald, Viktor; Zschaebitz, Stefanie
    Subgroup analysis of real-world efficacy of enfortumab vedotin in patients with metastatic/locally advanced urothelial carcinoma from a European database
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, e16562
    DOI (Open Access)
  • Heitmann, Jonas S.; Hackenbruch, Christopher; Walz, Juliane S.; Jung, Susanne; Pflügler, Martin; Schlenk, Richard F.; Ochsenreither, Sebastian; Hadaschik, Boris A.; Darr, Christopher; Jung, Gundram; Salih, Helmut R.
    Updated results on the bispecific PSMAxCD3 antibody CC-1 for treatment of prostate cancer
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 2536
    DOI (Open Access)
  • Handke, A.; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Y.; Hakansson, A.; Davicioni, E.; Hughes, J.; Song, H.; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S180
    DOI
  • Gafita, A.; Djaileb, L.; Rauscher, I.; Hadaschik, Boris; Herrmann, Ken; Weber, Manuel
    Assessment of Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-Resistant Prostate Cancer
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S544 – S545
    DOI
  • Heitmann, J. S.; Hackenbruch, C.; Walz, J. S.; Federmann, B.; Pfluegler, M.; Schlenk, R. F.; Ochsenreither, S.; Hadaschik, Boris; Darr, Christopher; Grünwald, Viktor; Jung, G.; Salih, H. R.
    Clinical development of the bispecific PSMAxCD3 antibody CC-1 for treatment of prostate cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 112
    DOI (Open Access)
  • Pedro, Costa Fragoso; Darr, Christopher; Moraitis, Alexandros; Kahl, T.; Engel, J.; Al-Nader, Mulham; Henning, Monika; Köllermann, J.; Kesch, Claudia; Krafft, Ulrich; Maurer, T.; Köhler, D.; Klutmann, S.; Falkenbach, F.; Kleesiek, Jens; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris
    Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S586
    DOI
  • Farolfi, A.; Armstrong, W.; Djaileb, L.; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. Suppl. 1, S. S92
    DOI
  • Farolfi, Andrea; Armstrong, Wesley; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Auerbach, Martin; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P843
  • Darr, Christopher; Fragoso Costa, Pedro; Kahl, T.; Alexandros, M.; Fendler, Wolfgang P.; Barbato, F.; Bartel, T.; Reis, H.; Köllermann, J.; Pullen, L.; Kesch, C.; Krafft, Ulrich; Kleesiek, Jens; Herrmann, Ken; Hadaschik, Boris A.
    Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
    38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,
    In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1, S. S687
    DOI
  • Váradi, M.; Horváth, O.; Fazekas, T.; Csizmarik, A.; Módos, O.; Széles, Á.; Kenessey, I.; Reis, H.; Oláh, C.; Hadaschik, Boris; Krafft, Ulrich; Ting, S.; Furka, A.; Nyirády, P.; Szarvas, T.
    Molecular analysis of urothelial carcinoma to predict the efficacy of immune checkpoint inhibitor therapy
    38th Annual European Association of Urology Congress (EAU) ; March 10 - 13, 2023, Milan, Italy,
    In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1: Abstracts EAU23, S. S1679 – S1680
    DOI
  • Pöttgen, Christoph; Khouya, Aymane; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago, Alina; Krafft, Ulrich; Hadaschik, Boris; Stuschke, Martin
    Online-adaptive Strahlentherapie beim muskelinvasiven Blasenkarzinom mit angepassten PTVSäumen : Vorteil gegenüber der IGRT zum Zeitpunkt der Adaptation und gute akkumulierte EUD zum Zeitpunkt der Applikation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S153
    DOI (Open Access)
  • Moraitis, Alexandros; Darr, Christopher; Kahl, T.; Püllen, Lukas; Jentzen, Walter; Kersting, David; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; Costa, Pedro Fragoso
    Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S131
    DOI
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Calais, Jeremie; Rowe, Steven; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias; Farolfi, Andrea
    Practical RECIP : Visual assessment of Response Evaluation Criteria In PSMA-PET/CT in metastatic castration-resistant prostate cancer
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 64, 2023, Nr. Suppl. 1, P1619
  • Fendler, Wolfgang; Seifert, Robert; Emmett, Louise; Herrmann, Ken; Hadaschik, Boris; Eiber, Matthias
    Prostate Cancer Molecular Imaging Standardized Evaluation : The PROMISE V2 Framework Including Response Evaluation for Clinical Trials
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S150
    DOI (Open Access)
  • Afferi, L.; Spahn, M.; Hayoz, S.; Hadaschik, Boris; Cathomas, R.; et al.
    Surgical safety and quality of radical cystectomy and pelvic lymph node dissection after neoadjuvant Durvalumab and Cisplatin/Gemcitabine for muscle invasive bladder cancer : Results from the SAKK 06/17 phase II study
    38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,
    In: European Urology. Amsterdam: Elsevier, Jg. 83, 2023, Nr. Supplement 1, S. S230 – S231
    DOI
  • Seifert, Robert; Emmett, L.; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang
    The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S177
    DOI
  • Darr, Christopher; Zschäbitz, S.; Niegisch, G.; Roghmann, F.; Ivanyi, P.; Zengerling, F.; Paffenholz, P.; Biernath, N.; Klee, M.; Klümper, N.; Tauber, R.; Hadaschik, Boris; Hilser, T.; Grünwald, Viktor
    Enfortumab Vedotin bei metastasiertem Urothelkarzinom : retrospektive, multizentrische Patientenkohorte
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 64
    DOI (Open Access)
  • Pabst, K. M.; Fendler, Wolfgang P.; Hadaschik, Boris; Kesch, C.; Hirmas, N.; Kessler, Lukas; Grünwald, Viktor; Hamacher, R.; Nader, M.; Berliner, C.; Umutlu, Lale; Püllen, Lukas; Herrmann, Ken; Lückerath, Katharina; Castellucci, P.; Fanti, S.; Mei, R.
    FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S118 – S119
    DOI (Open Access)
  • Zeuschner, P.; Siemer, S.; Stöckle, M.; Schiefelbein, F.; Schneller, A.; Schön, G.; Wiesinger, C.; Pfuner, J.; Ubrig, B.; Gloger, S.; Osmonov, D.; Eraky, A.; Witt, J.; Liakos, N.; Wagner, C.; Hadaschik, Boris; Radtke, J.P.; Al Nader, M.; Imkamp, F.; Kuczyk, M.; Huusmann, S.; Harke, N.
    Impact of surgical experience prior to robot-assisted partial nephrectomy on surgical outcomes : Large multicenter analysis with 2,500 patients
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S191 – S192
    DOI
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley Robert; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias; Fendler, Wolfgang; Eiber, Matthias
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    2022 ASCO Genitourinary Cancers Symposium, 17.-19.02.2022, San Fransisco,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 40, 2022, Nr. 6, Supplement: 2022 ASCO Genitourinary Cancers Symposium, jnumed.121.263072
    DOI (Open Access)
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.; Tauber, R.; Grogan, T.; Czernin, J.; Rettig, M.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.; Fendler, Wolfgang; Eiber, M.
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S269
    DOI (Open Access)
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.R.; Tauber, R.; Grogan, T.R.; Czernin, J.; Rettig, M.B.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.R.; Fendler, Wolfgang; Eiber, M.
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : An international multicenter study
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S794 – S795
    DOI
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. Suppl. 6, 42
    DOI, Online Volltext (Open Access)
  • Kibel, Adam S.; Gleave, Martin; Brookman-May, Sabine D.; Kim, Won; Evans, Christopher P.; Efstathiou, Eleni; Kantoff, Philip W.; Ross, Ashley; Shore, Neal D.; Briganti, Alberto; Hadaschik, Boris; Heidenreich, Axel; Rooney, Oliver Brendan; Tian, Shaozhou Ken; Wetherhold, Lisa; Xu, Weichun; Parsons, J. Kellogg; Yeruva, Kesav; Taplin, Mary-Ellen
    PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), 2022, TPS285
    DOI (Open Access)
  • Cathomas, Richard; Rothschild, Sacha; Hayoz, Stefanie; Spahn, Martin; Özdemir, Berna; Kiss, Bernhard; Erdmann, Andreas; Aeppli, Stefanie; Mach, Nicolas; Strebel, Raeto; Hadaschik, Boris; Berthold, Dominik R.; Pless, Miklos; Zihler, Deborah; Schmid, Mathias; Schneider, Martina; Musilova, Jana; Petrausch, Ulf
    Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC) : Primary analysis of the single arm phase II trial SAKK 06/17
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. 4515
    DOI (Open Access)
  • Maier, D.; Vehreschild, J. J.; Uhl, B.; Grünwald, Viktor; Hadaschik, Boris; Palm, S.; Stuschke, Martin; Esins, M.; Ressing, F.; Schuler, Martin; Serve, H.; et al.
    Profil der multizentrischen Kohorte der Klinischen Kommunicationsplattform des Deutschen Konsortiums für Translationale Krebsforschung (DKTK)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 13
    DOI (Open Access)
  • Kesch, C.V.; Pantea, V.; Soeterik, T.; Marquis, A.; La Bombarda, G.; Morlacco, A.; Barletta, F.; Preisser, F.; Zattoni, F.; Marra, G.; Van Den Bergh, R.C.N.; Radtke, J.P.; Hadaschik, Boris; Gandaglia, G.
    Risk of adverse outcomes after prostatectomy in patients diagnosed with IUSP <= 2 prostate cancer on MRI/TRUS fusion biopsy
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S438
    DOI
  • Harke, N.N.; Schiefelbein, F.; Schneller, A.; Schoen, G.; Wiesinger, C.G.; Pfuner, J.; Falkensammer, E.; Gilbert, N.; Eraky, A.; Zimmermanns, V.; Paramythelli, I.; Hadaschik, Boris; Radtke, J. P.; Darr, Christopher; Kriegmair, M.C.; Flintrop, M.; Wolters, M.; Faraj Tabrizi, P.; Kuczyk, M.A.; Osmonov, D.
    Robot-assisted partial nephrectomy for multiple renal tumors : a multicenter analysis
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology. Amsterdam: Elsevier, Jg. 81, 2022, Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S543
    DOI
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120
    DOI (Open Access)
  • Hamacher, R.; Möller, L.; Kajüter, H.; Eisfeld, C.; Assahub, M.; Darr, Christopher; Hadaschik, Boris; Bauer, Sebastian; Stang, Andreas; Grünwald, Viktor
    Urogenitale Sarkome im Erwachsenenalter : eine populationsbasierte Analyse von Tumorcharakteristika, Inzidenz und Überleben in Nordrhein-Westfalen (NRW)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 63
    DOI (Open Access)
  • Saner, Y.; Wiesenfarth, M.; Tschirdewahn, Stephan; Püllen, Lukas; Bonekamp, D.; Krafft, Ulrich; Kesch, C.; Darr, Christopher; Forsting, Michael; Umutlu, Lale; Hadaschik, Boris A.; Radtke, J. P.
    Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging/transrectal ultrasonography-fusion biopsy : A prospective, randomized comparison to conventional target biopsy
    EAU21 Virtual Congress; 8-12 July 2021; Virtual,
    In: European Urology. Amsterdam: Elsevier, Jg. 79, 2021, Nr. Suppl. 1, S. S1272
    DOI
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, M.
    Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    EANM‘21 ; 34th Annual Congress of the European Association of Nuclear Medicine ; October 20-23, 2021, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S311 – S312
    DOI (Open Access)
  • Ferdinandus, Justin; Maríc, Ines; Darr, Christopher; Kesch, Claudia; Hilser, Thomas; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma
    2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. Suppl. 15, S. e16564
    DOI (Open Access)
  • Fragoso Costa, Pedro; Püllen, Lukas; Klose, J. M.; Iking, J.; Sandach, Patrick; Staniszewska, M.; Herrmann, Ken; Radtke, J. P.; Tschirdewahn, Stephan; Hadaschik, Boris; Fendler, Wolfgang; Darr, Christopher
    Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse model
    EANM‘21, Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. S17
    DOI (Open Access)
  • Hadaschik, Boris
    Initial experience from a multicentre clinical trial evaluating the safety and performance of a drop-in gamma probe for sentinel lymph node biopsy in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 554
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R; Tauber, Robert; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter study
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 5066 – 5066
    DOI (Open Access)
  • Hadaschik, Boris; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang
    Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective study
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 63 – S64
  • Hadaschik, Boris; Fanti, S.; Ost, P.; Tunariu, N.; de Nunzio, C.; Antoni, L.; Lukac, M.; Martin, J.; Pissart, G.; Wapenaar, R.; Mottet, N.
    PRIMORDIUM : A randomized, international, trial-in-progress of adding apalutamide to radiotherapy and an LHRH agonist in high-risk patients with PSMA-PET-positive hormone-sensitive prostate cancer
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. 676 – S677
    DOI (Open Access)
  • Calais, Jeremie; Zhu, Shaojun; Hrimas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study Protocol
    AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 81, 2021, Nr. Suppl. 13, CT257
    DOI
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar Upadhyaya; Nickols, Nicholas George; Elashoff, David; Fendler, Wolfgang
    Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
    2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 6, Supplement, S. TPS172
    DOI (Open Access)
  • Junquera, Jose Maria Abascal; Walz, Jochen Christoph; Hadaschik, Boris; Adshead, Jim; Everaerts, Wouter; Goffin, Karolien; Grootendorst, Maarten Ruben; Oldfield, Francesca; Fusco, Antoni Mestre; Vidal-Sicart, Sergi; Fumado, Lluis
    The SENSEI laparoscopic tethered gamma probe for sentinel lymph node biopsy in prostate cancer : Initial experience from a multicenter clinical trial
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 899
    Online Volltext
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Graff, Julie N; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; De Porre, Peter; Smith, Andressa; Brookman-May, Sabine Doris; Li, Susan; Zhang, Ke; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Smith, Matthew Raymond
    Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15_Suppl., S. 5516
    DOI (Open Access)
  • Oudard, S.; Hadaschik, Boris; Saad, Fred; Cella, David; Basch, Ethan; Mainwaring, Paul; Graff, J.N.; Dibaj, Seyedeh S.; Li, S.; Brookman-May, S.D.; De Porre, P.; Trudeau, Jeremiah J.; Small, E.J.; Smith, Mitchell R.
    Health-related quality of life (HRQoL) at final analysis of the SPARTAN study of apalutamide (APA) vs placebo (PBO) in patients (pts) with non-metastatic castration-resistant prostate cancer (nmCRPC) receiving androgen deprivation therapy (ADT)
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S521
    DOI (Open Access)
  • Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Barbato, Francesco; Weber, Manuel; Ferdinandus, Justin; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; et al.
    Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PET
    Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July, 11-14, 2020, Virtual,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 1270
    Online Volltext (Open Access)
  • Hadaschik, Boris
    Molecular determinants of prostate specific antigen (PSA) kinetics and clinical response to apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in SPARTAN
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15_Suppl.
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Ferdinandus, Justin; Nader, Michael; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang
    PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imaging
    Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), July 11-14, 2020, Virtual,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 1260
    Online Volltext
  • Uemura, H.; Lee, J. Y.; Oudard, S.; Hadaschik, Boris A.; Saad, F.; Cella, D.; Basch, E.; Graff, J. N.; Dibaj, S.; Li, S.; Brookman-May, S. D.; De Porre, P.; Bevans, K.; Trudeau, J.; Smith, M. R.; Small, E. J.
    Patient-reported sexual and urinary function in nonmetastatic castration-resistant prostate cancer (nmCRPC) when treated with apalutamide (APA) vs placebo (PBO) and ongoing androgen deprivation therapy (ADT) in SPARTAN
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Supplement 6, S. S1327
    DOI (Open Access)
  • Fragoso Costa, P.; Sonnenschein, W.; Binse, Ina; Fendler, Wolfgang P.; Herrmann, Ken; Grootendorst, M. R.; Krafft, Ulrich; Radtke, J. P.; Hadaschik, Boris; Darr, Christopher
    Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S212
    DOI (Open Access)
  • Feng, Felix; Thomas, Shibu; Gormley, Michael; Lopez-Gitlitz, Angela; Yu, Margaret K.; Cheng, Shinta; Ricci, Deborah S.; Rooney, Brendan; Mainwaring, Paul N.; Olmos, David; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris; Fishbane, Nick; Davicioni, Elai; Liu, Yang; Small, Eric J.; Smith, Matthew R.
    Abstract CT129: (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the SPARTAN study
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 79, 2019, Nr. Suppl. 13
    DOI (Open Access)
  • Graff, Julie Nicole; Smith, Matthew Raymond; Saad, Fred; Hadaschik, Boris; Uemura, Hiroji; Lee, Ji Youl; Mainwaring, Paul N.; Olmos, David; Oudard, Stephane; Londhe, Anil; Bhaumik, Amitabha; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Small, Eric Jay
    Age-related efficacy and safety of apalutamide (APA) plus ongoing androgen deprivation therapy (ADT) in subgroups of patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): Post hoc analysis of SPARTAN
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 37, 2019, Nr. 15, S. 5024 – 5024
    DOI (Open Access)
  • Pollock, YaoYao Guan; Smith, Matthew Raymond; Saad, Fred; Chowdhury, Simon; Oudard, Stephane; Hadaschik, Boris; Olmos, David; Mainwaring, Paul N.; Lee, Ji Youl; Uemura, Hiroji; Bhaumik, Amitabha; Londhe, Anil; Rooney, Oliver Brendan; Lopez-Gitlitz, Angela; Mundle, Suneel; Cheng, Shinta; Small, Eric Jay
    Predictors of falls and fractures in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with apalutamide (APA) plus ongoing androgen deprivation therapy (ADT)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 37, 2019, Nr. 15, S. 5025 – 5025
    DOI (Open Access)
  • Small, Eric Jay; Cella, David F.; McQuarrie, Kelly; Saad, Fred; Hadaschik, Boris; Graff, Julie N.; Uemura, H.; Oudard, Stephané Marie; Yu, M.K.; Hudgens, Stacie A.; Lopez-Gitlitz, Angela; Rooney, B.; Morris, Michael J.; Smith, Matthew Raymond
    Health-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN : A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 29, 2018, Nr. Suppl. 8, S. viii276 – viii277
    DOI (Open Access)
  • Small, Eric Jay; Saad, Fred; Zheng, Ying; Pan, Feng; Mehra, Maneesha; Lawson, Joe; Hadaschik, Boris; Uemura, Hiroji; Lee, Ji Youl; Mainwaring, Paul N.; Smith, Matthew Raymond
    Impact of intervening in high-risk nonmetastatic castration-resistant prostate cancer (HRnmCRPC) on metastatic castration-resistant prostate cancer (mCRPC) disease burden
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. Suppl. 15, S. e17010 – e17010
    DOI (Open Access)
  • Afshar-Oromieh, A.; Debus, N.; Uhrig, M.; Hope, T.A.; Evans, M. J.; Holland-Letz, T.; Giesel, F.; Kopka, K.; Hadaschik, Boris; Kratochwil, C.; Haberkorn, U.
    Impact of long-term androgen deprivation therapy on PSMA-ligand PET/CT in patients with castration sensitive prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 22 – S23
    DOI
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology. Amsterdam: Elsevier, Jg. 31, 2018, Nr. Suppl. 2, S. 378
    DOI (Open Access)
  • Small, Eric Jay; Saad, Fred; Rathkopf, Dana E.; Hadaschik, Boris; Chowdhury, Simon; Yu, Margaret K.; Lopez-Gitlitz, Angela; Rooney, Oliver Brendan; Shu, Youyi; Darif, Mohamed; Smith, Matthew Raymond
    Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) : An analysis from the phase 3 SPARTAN trial
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. Suppl. 15, S. 5034 – 5034
    DOI (Open Access)
  • Smith, Matthew Raymond; Saad, Fred; Rathkopf, Dana E.; Hadaschik, Boris; Chowdhury, Simon; Yu, Margaret K.; Lopez-Gitlitz, Angela; Rooney, Oliver Brendan; Darif, Mohamed; Small, Eric Jay
    Relationship of time to metastasis (TTM) and site of metastases in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) : Results from the phase 3 SPARTAN trial
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. Suppl. 15, S. 5033 – 5033
    DOI (Open Access)
  • Small, Eric Jay; Saad, Fred; Chowdhury, Simon; Hadaschik, Boris A.; Graff, Julie Nicole; Olmos, David; Mainwaring, Paul N.; Uemura, Hiroji; Lopez-Gitlitz, Angela; Trudel, Geralyn Carol; Espina, Byron M.; Shu, Youyi; Park, Youn C.; Rackoff, Wayne R.; Yu, Margaret K.; Smith, Matthew Raymond
    SPARTAN, a phase 3 double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. 6 Suppl., S. 161
    DOI (Open Access)
  • Hadaschik, Boris; Small, E. J.; Saad, F.; Chowdhury, S.; Graff, J. N.; Olmos, D.; Mainwaring, P. N.; Uemura, H.; Lopez-Gitlitz, A.; Trudel, G. C.; Espina, B. M.; Shu, Y.; Park, Y. C.; Rackoff, W. R.; Yu, M. K.; Smith, M. R.; SPARTAN Investigators
    SPARTAN, a phase 3 double-blind, randomized study of apalutamide versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 43
    DOI (Open Access)

    • Beiträge in Sammelwerken und Tagungsbänden

  • Schostak, M.; Wendler, J.J.; Baumunk, D.; Blana, A.; Ganzer, R.; Franiel, T.; Hadaschik, Boris; Henkel, T.; Köhrmann, K.U.; Köllermann, J.; Kuru, T.; Machtens, S.; Roosen, A.; Salomon, G.; Schlemmer, H.P.; Sentker, L.; Witzsch, U.; Liehr, U.B.
    Treatment of Small Renal Masses
    In: Urologic Oncology / Merseburger, Axel S.; Burger, Maximilian. Cham: Springer International Publishing, 2019, S. 555 – 568
    DOI
  • Schütz, Viktoria; Kesch, Claudia; Dieffenbacher, Svenja; Bonekamp, David; Hadaschik, Boris; Hohenfellner, Markus; Radtke, Jan Philipp
    Multiparametric MRI and MRI/TRUS Fusion Guided Biopsy for the Diagnosis of Prostate Cancer
    In: Molecular & Diagnostic Imaging in Prostate Cancer: Clinical Applications and Treatment Strategies / Schatten, Heide (Hrsg.). Cham: Springer, 2018, S. 87 – 98
    DOI

    • Poster / Posterbeiträge

  • Pabst, Kim M.; Bartel, Timo; Sandach, Patrick; Laschinsky, Christina; Weber, Manuel M.; Kessler, Lukas; Küper, Alina T.; Hadaschik, Boris A.; Kesch, Claudia; Hamacher, Rainer; Kasper, Stefan; Podleska, Lars E.; Siveke, Jens T.; Eckstein, Markus; von Tresckow, Bastian; Kuemmel, Sherko; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang P.
    68Ga-FAPI-46 PET/CT for cancer imaging : Results of a single-center, prospective, interventional, single-arm clinical trial
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 457
    DOI
  • Kesch, Claudia; Meyer, Volker; Praus, Christine; Fragoso Costa, Pedro; Ingenwerth, Marc; Darr, Christopher; Radtke, Jan Philipp; Theysohn, Jens M; Schaarschmidt, Benedikt; Reis, Henning; Fendler, Wolfgang Peter; Grünwald, Viktor; Hadaschik, Boris A.; Herrmann, Ken
    A phase I/II study of neoadjuvant, intra-arterial administration of (177Lu)lutetium vipivotide tetraxetan in subjects with high-risk, localised or locally advanced prostate cancer (LUPUS)
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, TPS431
    DOI
  • Hadaschik, Boris A.; Von Amsberg, Gunhild; Herrmann, Ken; Merseburger, Axel Stuart; Goebell, Peter J.; Belleville, Erik; Fasching, Peter A.; Haeberle, Lothar; Roessler, Andrea; Grimm, Marc-Oliver
    Prostate Cancer Real World Evidence Registry (PROCARE) : Recurrent and metastatic prostate cancer
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, TPS274
    DOI
  • Fendler, Wolfgang Peter; Karpinski, Madeleine J.; Hoberück, Sebastian; Rauscher, Isabel; Unterrainer, Lena; Rasul, Sazan; Bjartell, Anders; Lanfranchi, Francesco; Di Giorgio, Andrea; Pfob, Christian Helmut; Soeterik, Timo; Goffin, Karolien; Kind, Felix; Miksch, Jonathan; Calais, Jeremie; Hofman, Michael S.; Hope, Thomas A.; Herrmann, Ken; Hadaschik, Boris A.; Rahbar, Kambiz; PROMISE Registry Group
    Prostate cancer risk groups by PSMA-PET PROMISE (PPP) : Results from an international multi-center registry study
    2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 266
    DOI
  • Krafft, Ulrich; Grünwald, Viktor; Fendler, Wolfgang P.; Herrmann, Ken; Reis, Henning; Roghmann, Florian; Rahbar, Kambiz; Heidenreich, Axel; Giesel, Frederik; Niegisch, Guenter; Hadaschik, Boris A.
    A randomized phase I/II study of neoadjuvant treatment with 177-Lutetium-PSMA-617 with or without ipilimumab in patients with very high-risk prostate cancer who are candidates for radical prostatectomy (NEPI trial)
    2024 ASCO Genitourinary Cancers Symposium, January 25-27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, TPS352
    DOI
  • Hadaschik, Boris A.; Mottet, Nicolas; Ost, Piet; De Nunzio, Cosimo; Tunariu, Nina; Zaucha, Renata; Brasso, Klaus; Osman-Garcia, Ignacio; Tural, Deniz; Lukac, Martin; Stitou, Hind; Pissart, Geneviève; Efficace, Michela; Fanti, Stefano
    Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM study
    2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Supplement 4, S. 119 – 119
    DOI
  • Kersting, David; Kim, Moon-Sung; Püllen, Lukas; Seidl-Rathkopf, Kathi; Schinwald, Nicole; Mpofu, Philani; Altomare, Ivy; Sujenthiran, Arun; Royce, Trevor Joseph; Buhl, Christoph; Grünwald, Viktor; Herrmann, Ken; Kleesiek, Jens; Hadaschik, Boris A.
    Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting
    2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 143
    DOI
  • Gartrell, Benjamin Adam; Phalguni, Angaja; Mundle, Suneel; McCarthy, Sharon; Brookman-May, Sabine D.; De Solda, Francesco; Jain, Ruhee; Ploussard, Guillaume; Hadaschik, Boris A.
    Influential factors impacting treatment (tx) decision making (TDM) and decision regret (DR) in patients (pts) with localized or locally advanced prostate cancer (LPC/LAPC).
    2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 294
    DOI
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris A.; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea
    Response evaluation criteria in PSMA PET/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer
    2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 45
    DOI
  • Seitzer, Konstantin Egon; Darr, Christopher; Hilser, Thomas; Schrader, Andres Jan; Huberth, Linda; Mausbach, Anne; Janssen, Martin; Krabbe, Laura-Maria; Heitplatz, Barbara; Hadaschik, Boris A.; Boegemann, Martin; Schlack, Katrin; Grünwald, Viktor
    Systemic and surgical treatment in renal cell carcinoma : Does timing matter?
    2024 ASCO Genitourinary Cancers Symposium, January 25 - 27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. 4, Supplement, 417
    DOI
  • Nikitas, John; Lam, Ethan C.; Booker, Kiara M; Fendler, Wolfgang P.; Eiber, Matthias; Hadaschik, Boris A.; Herrmann, Ken; Hirmas, Nader; Lanzafame, Helena; Stuschke, Martin; Czernin, Johannes; Steinberg, Michael L.; Nickols, Nicholas George; Kishan, Amar Upadhyaya; Calais, Jeremie
    Update from the PSMA-dRT trial : A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer
    2024 ASCO Genitourinary Cancers Symposium, January 25–27, 2024, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Supplement 4, S. 291 – 291
    DOI
  • Schürger, N.; Darr, Christopher; Möller, L.; Reis, H.; Isgandarov, A.; Thomas, H.; Stang, Andreas; Hadaschik, Boris; Kajüter, H.; Grünwald, Viktor
    Histotype-specic overall survival of patients with urothelial carcinoma from the largest EU cancer registry in North Rhine-Westphalia, Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 321 – 322
    DOI (Open Access)
  • Darr, Christopher; Zschäbitz, S.; Niegisch, G.; Roghmann, F.; Ivanyi, P.; Zengerling, F.; Paffenholz, P.; Biernath, N.; Klee, M.; Klümper, N.; Tauber, R.L.; Hadaschik, Boris; Hilser, T.; Grünwald, Viktor
    Enfortumab vedotin in metastatic urothelial carcinoma : Retrospective multicentre patient cohort
    Annual Meeting of the European-Society-for-Medical-Oncology (ESMO): SEP 09-13, 2022; Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Suppl. 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1342
    DOI (Open Access)
  • Schürger, N.; Darr, Christopher; Möller, L.; Reis, Henning; Isgandarov, A.; Hilser, Thomas; Stang, Andreas; Hadaschik, Boris A.; Kajüter, H.; Grünwald, Viktor
    Inzidenz und Überleben von Patienten mit Urothelkarzinom in Nordrhein-Westfalen (NRW) : Analyse des Landeskrebsregister (LKR) von den Jahren 2008-2019
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 318
    DOI (Open Access)
  • Isgandarov, A.; Darr, Christopher; Hilser, T.; Al-Nader, M.; Hadaschik, Boris A.; Grünwald, Viktor
    Klinische Wirksamkeit kontemporärer Systemtherapie mit Immuntherapie beim metastasierten Urothelkarzinom, eine monozentrische Evaluation
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 318
    DOI (Open Access)